BREAKTHROUGH T1D: Form 990, tax year 2018

View the entire original 990 at ProPublica ↗

Organization: BREAKTHROUGH T1D (EIN 23-1907729)
Tax period: 2018-07-01 to 2019-06-30
Filed: 2020-02-12
IRS object ID: 202000439349301520
Schema version: 2018v3.1
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule C
Schedule D
Schedule F
Schedule G
Schedule I
Schedule J
Schedule M
Schedule O
Schedule R

Return header ReturnHeader

Field	Value	IRS element (for citing)
Return	2020-02-12T13:30:15-06:00	ReturnTs
Tax Period End	2019-06-30	TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

Field	Value	IRS element (for citing)
Business Name Line1	KPMG LLP	BusinessNameLine1Txt

Preparer US Address PreparerUSAddress

Field	Value	IRS element (for citing)
Address Line1	345 PARK AVE	AddressLine1Txt
City	NEW YORK	CityNm
State Abbreviation	NY	StateAbbreviationCd
ZIP	10154	ZIPCd

Field	Value	IRS element (for citing)
Return Type	990	ReturnTypeCd
Tax Period Begin	2018-07-01	TaxPeriodBeginDt

Filer Filer

Field	Value	IRS element (for citing)
EIN	231907729	EIN

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	JDRF INTERNATIONAL	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
In Care Of	% EMMA PANGILINAN-ROSALES	InCareOfNm
Business Name Control	JDRF	BusinessNameControlTxt
Phone	2127859500	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	200 VESEY STREET 28TH FLOOR	AddressLine1Txt
City	NEW YORK	CityNm
State Abbreviation	NY	StateAbbreviationCd
ZIP	10281	ZIPCd

Business Officer BusinessOfficerGrp

Field	Value	IRS element (for citing)
Person	JOANNE MARTZ	PersonNm
Person Title	CFO	PersonTitleTxt
Signature	2020-02-11	SignatureDt
Discuss With Paid Preparer	Yes (true)	DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

Field	Value	IRS element (for citing)
Preparer Person	DEVIN DUNCAN	PreparerPersonNm
PTIN	P01249521	PTIN
Phone	2127859700	PhoneNum

Filing Security Information FilingSecurityInformation

IP Address IPAddress

Field	Value	IRS element (for citing)
I Pv4 Address	167.68.102.5	IPv4AddressTxt

Field	Value	IRS element (for citing)
Federal Original Submission Id	20543020200435000000	FederalOriginalSubmissionId
Federal Original Submission Id	2020-02-12	FederalOriginalSubmissionIdDt
Filing License Type	P	FilingLicenseTypeCd
At Submission Creation Device Id	E665B3E7A8D0C3A51E67724EBAB5121B0EE8EB14	AtSubmissionCreationDeviceId
At Submission Filing Device Id	B09A8F7452AAEB109EF01FBCB66ABFE0CB6B8889	AtSubmissionFilingDeviceId

Field	Value	IRS element (for citing)
Tax	2018	TaxYr
Build TS	2020-09-23 17:36:50Z	BuildTS

Form 990 IRS990

Field	Value	IRS element (for citing)
Address Change	Yes (X)	AddressChangeInd
Principal Officer	AARON KOWALSKI	PrincipalOfficerNm

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	200 VESEY STREET 28TH FLOOR	AddressLine1Txt
City	NEW YORK	CityNm
State Abbreviation	NY	StateAbbreviationCd
ZIP	10281	ZIPCd

Field	Value	IRS element (for citing)
Gross Receipts	$306,560,671	GrossReceiptsAmt
Group Return For Affiliates	false	GroupReturnForAffiliatesInd
Organization501c3	Yes (X)	Organization501c3Ind
Website Address	www.jdrf.org	WebsiteAddressTxt
Type Of Organization Corp	Yes (X)	TypeOfOrganizationCorpInd
Formation	1970	FormationYr
Legal Domicile State	PA	LegalDomicileStateCd
Activity Or Mission	Improving lives today and tomorrow by accelerating life-changing breakthroughs to cure, prevent and treat T1D and its complications. SEE SCHEDULE O	ActivityOrMissionDesc
Voting Members Governing Body	35	VotingMembersGoverningBodyCnt
Voting Members Independent	35	VotingMembersIndependentCnt
Total Employee	881	TotalEmployeeCnt
Total Volunteers	235000	TotalVolunteersCnt
Total Gross UBI	$225,709	TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm	$186,965	NetUnrelatedBusTxblIncmAmt
PY Contributions Grants	$219,968,105	PYContributionsGrantsAmt
CY Contributions Grants	$215,659,011	CYContributionsGrantsAmt
PY Program Service Revenue	$0	PYProgramServiceRevenueAmt
CY Program Service Revenue	$0	CYProgramServiceRevenueAmt
PY Investment Income	$7,177,001	PYInvestmentIncomeAmt
CY Investment Income	$19,973,309	CYInvestmentIncomeAmt
PY Other Revenue	$2,970,878	PYOtherRevenueAmt
CY Other Revenue	$3,697,145	CYOtherRevenueAmt
PY Total Revenue	$230,115,984	PYTotalRevenueAmt
CY Total Revenue	$239,329,465	CYTotalRevenueAmt
PY Grants And Similar Paid	$84,651,980	PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid	$89,137,491	CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members	$0	PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members	$0	CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid	$81,433,187	PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid	$80,309,185	CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns	$2,328	PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns	$339,984	CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense	$31,501,935	CYTotalFundraisingExpenseAmt
PY Other Expenses	$42,340,180	PYOtherExpensesAmt
CY Other Expenses	$42,783,392	CYOtherExpensesAmt
PY Total Expenses	$208,427,675	PYTotalExpensesAmt
CY Total Expenses	$212,570,052	CYTotalExpensesAmt
PY Revenues Less Expenses	$21,688,309	PYRevenuesLessExpensesAmt
CY Revenues Less Expenses	$26,759,413	CYRevenuesLessExpensesAmt
Total Assets BOY	$226,353,181	TotalAssetsBOYAmt
Total Assets EOY	$244,434,766	TotalAssetsEOYAmt
Total Liabilities BOY	$129,947,696	TotalLiabilitiesBOYAmt
Total Liabilities EOY	$128,633,286	TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY	$96,405,485	NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY	$115,801,480	NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part III	Yes (X)	InfoInScheduleOPartIIIInd
Mission	AT JDRF, WE WORK TIRELESSLY TO ACCELERATE BREAKTHROUGHS TO CURE, PREVENT AND TREAT TYPE 1 DIABETES (T1D). WE CONTINUALLY EXPAND OUR SCIENTIFIC KNOWLEDGE, OUR CONNECTIONS AND COLLABORATIONS, OUR PARTNERS AND GLOBAL PRESENCE TO UNLOCK THE SCIENCE THAT WILL STOP T1D. WHILE WE FIGHT FOR A CURE, WE STRIVE JUST AS HARD TO DEVELOP THERAPIES TO HELP PEOPLE RIGHT NOW. JDRF AND OUR SCIENTISTS ARE LEADING T1D RESEARCH AROUND THE WORLD. WE ADDRESS KEY GAPS TO MOVE RESEARCH FASTER AND FARTHER ACROSS THE DEVELOPMENT PIPELINE AND TO TRANSLATE BREAKTHROUGHS INTO NEW THERAPIES FOR PEOPLE WITH T1D. THIS ENABLES US TO ADVANCE SCIENCE WITH THE MOST POTENTIAL AND TO DRIVE RESEARCH THAT ATTRACTS MORE RESOURCES AND SCIENTIFIC EXPERTISE TO THE FIELD. WE INVEST IN THE EARLY STAGES, ALLOWING RESEARCHERS TO PURSUE INNOVATIVE IDEAS AND APPROACHES THAT WILL LEAD TO BREAKTHROUGH TREATMENTS. JDRF ALSO WORKS TO DRIVE NEW THERAPIES AND TECHNOLOGIES TO MARKET SO THEY GET INTO THE HANDS OF PEOPLE WITH T1D MORE QUICKLY.	MissionDesc
Significant New Program Srvc	false	SignificantNewProgramSrvcInd
Significant Change	false	SignificantChangeInd
Expense	$89,137,491	ExpenseAmt
Grant	$89,137,491	GrantAmt
Desc	RESEARCH FUNDING - FOR THE FY19 PERIOD ENDING JUNE 30, 2019, JDRF DIRECTLY FUNDED RESEARCH GRANTS AND INDUSTRY AGREEMENTS FOR WHICH $89 MILLION IN RESEARCH GRANT EXPENSE, NET WAS RECOGNIZED ACCORDING TO GAAP AND EXCLUDING $21 MILLION OF PROGRAMMATIC RESEARCH INVESTMENTS WHICH ARE RECORDED TO THE ORGANIZATION'S BALANCE SHEET. FOR AN EXPANDED DESCRIPTION OF PROGRAM SERVICE ACTIVITIES RELATED TO DIRECT RESEARCH FUNDING, SEE SCHEDULE O.	Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

Field	Value	IRS element (for citing)
Expense	$16,986,262	ExpenseAmt
Desc	RESEARCH SUPPORT - JDRF MAINTAINS AN IN-HOUSE TEAM OF SKILLED SCIENTIFIC, MEDICAL, POLICY AND GOVERNMENT RELATIONS PROFESSIONALS WHO PLAY A CRITICAL ROLE IN LEADING AND SUPPORTING THE EVALUATION OF RESEARCH FUNDING OPPORTUNITIES BY JDRF AND INFLUENCING RESEARCH DIRECTION AND THE DISBURSEMENT OF RESEARCH FUNDS FROM OTHERS. THESE PROFESSIONALS ALSO WORK WITH REGULATORY AND POLICY OFFICIALS TO ENSURE THAT RESEARCH CAN PROCEED WITHOUT DELAY AND RESULTS ARE UNDERSTOOD BY HEALTHCARE DECISION MAKERS.FOR AN EXPANDED DESCRIPTION OF PROGRAM SERVICE ACTIVITIES RELATED TO RESEARCH SUPPORT, SEE SCHEDULE O.	Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

Field	Value	IRS element (for citing)
Expense	$53,426,056	ExpenseAmt
Desc	PUBLIC EDUCATION AND OUTREACH - JDRF EDUCATES THE COMMUNITY AND PROVIDES OUTREACH SERVICES TO NEWLY DIAGNOSED CHILDREN AND ADULTS, THEIR FAMILIES AND OTHERS ABOUT T1D AND ITS COMPLICATIONS.FOR AN EXPANDED DESCRIPTION OF PROGRAM SERVICE ACTIVITIES RELATED TO PUBLIC EDUCATION AND OUTREACH, SEE SCHEDULE O.	Desc

Field	Value	IRS element (for citing)
Total Program Service Expenses	$159,549,809	TotalProgramServiceExpensesAmt
Described In Section501c3	Yes (true)	DescribedInSection501c3Ind
Schedule B Required	false	ScheduleBRequiredInd
Political Campaign Acty	false	PoliticalCampaignActyInd
Lobbying Activities	Yes (true)	LobbyingActivitiesInd
Subject To Proxy Tax	false	SubjectToProxyTaxInd
Donor Advised Fund	false	DonorAdvisedFundInd
Conservation Easements	false	ConservationEasementsInd
Collections Of Art	false	CollectionsOfArtInd
Credit Counseling	false	CreditCounselingInd
Temp Or Permanent Endowments	Yes (true)	TempOrPermanentEndowmentsInd
Report Land Building Equipment	Yes (true)	ReportLandBuildingEquipmentInd
Report Investments Other Sec	false	ReportInvestmentsOtherSecInd
Report Program Related Invst	Yes (true)	ReportProgramRelatedInvstInd
Report Other Assets	false	ReportOtherAssetsInd
Report Other Liabilities	Yes (true)	ReportOtherLiabilitiesInd
Include FIN48 Footnote	Yes (true)	IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt	false	IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt	Yes (true)	ConsolidatedAuditFinclStmtInd
School Operating	false	SchoolOperatingInd
Foreign Office	Yes (true)	ForeignOfficeInd
Foreign Activities	Yes (true)	ForeignActivitiesInd
More Than5000 K To Org	Yes (true)	MoreThan5000KToOrgInd
More Than5000 K To Individuals	false	MoreThan5000KToIndividualsInd
Professional Fundraising	Yes (true)	ProfessionalFundraisingInd
Fundraising Activities	Yes (true)	FundraisingActivitiesInd
Gaming Activities	Yes (true)	GamingActivitiesInd
Operate Hospital	false	OperateHospitalInd
Grants To Organizations	Yes (true)	GrantsToOrganizationsInd
Grants To Individuals	false	GrantsToIndividualsInd
Schedule J Required	Yes (true)	ScheduleJRequiredInd
Tax Exempt Bonds	false	TaxExemptBondsInd
Engaged In Excess Benefit Trans	false	EngagedInExcessBenefitTransInd
PY Excess Benefit Trans	false	PYExcessBenefitTransInd
Loan Outstanding	false	LoanOutstandingInd
Grant To Related Person	false	GrantToRelatedPersonInd
Business Rln With Org Mem	false	BusinessRlnWithOrgMemInd
Business Rln With Fam Mem	false	BusinessRlnWithFamMemInd
Business Rln With Officer Ent	false	BusinessRlnWithOfficerEntInd
Deductible Non Cash Contri	Yes (true)	DeductibleNonCashContriInd
Deductible Art Contribution	false	DeductibleArtContributionInd
Terminate Operations	false	TerminateOperationsInd
Partial Liquidation	false	PartialLiquidationInd
Disregarded Entity	Yes (true)	DisregardedEntityInd
Related Entity	Yes (true)	RelatedEntityInd
Related Organization Ctrl Ent	Yes (true)	RelatedOrganizationCtrlEntInd
Transaction With Control Ent	false	TransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org	false	TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp	false	ActivitiesConductedPrtshpInd
Schedule O Required	Yes (true)	ScheduleORequiredInd
IRP Document	951	IRPDocumentCnt
IRP Document W2 G	6	IRPDocumentW2GCnt
Backup Wthld Compliance	Yes (true)	BackupWthldComplianceInd
Employee	881	EmployeeCnt
Employment Tax Returns Filed	Yes (true)	EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit	Yes (true)	UnrelatedBusIncmOverLimitInd
Form990 T Filed	Yes (true)	Form990TFiledInd
Foreign Financial Account	Yes (true)	ForeignFinancialAccountInd
Foreign Country	IS	ForeignCountryCd
Foreign Country	NL	ForeignCountryCd
Prohibited Tax Shelter Trans	false	ProhibitedTaxShelterTransInd
Taxable Party Notification	false	TaxablePartyNotificationInd
Nondeductible Contributions	false	NondeductibleContributionsInd
Quid Pro Quo Contributions	Yes (true)	QuidProQuoContributionsInd
Quid Pro Quo Contri Discl	Yes (true)	QuidProQuoContriDisclInd
Form8282 Property Disposed Of	false	Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct	false	RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct	false	PayPremiumsPrsnlBnftCntrctInd
Form1098 C Filed	Yes (true)	Form1098CFiledInd
Indoor Tanning Services	false	IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt	false	SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc	false	SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VI	Yes (X)	InfoInScheduleOPartVIInd
Governing Body Voting Members	35	GoverningBodyVotingMembersCnt
Independent Voting Member	35	IndependentVotingMemberCnt
Family Or Business Rln	false	FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties	false	DelegationOfMgmtDutiesInd
Change To Org Documents	false	ChangeToOrgDocumentsInd
Material Diversion Or Misuse	false	MaterialDiversionOrMisuseInd
Members Or Stockholders	false	MembersOrStockholdersInd
Election Of Board Members	false	ElectionOfBoardMembersInd
Decisions Subject To Approva	false	DecisionsSubjectToApprovaInd
Minutes Of Governing Body	Yes (true)	MinutesOfGoverningBodyInd
Minutes Of Committees	Yes (true)	MinutesOfCommitteesInd
Officer Mailing Address	false	OfficerMailingAddressInd
Local Chapters	Yes (true)	LocalChaptersInd
Policies Reference Chapters	Yes (true)	PoliciesReferenceChaptersInd
Form990 Provided To Gvrn Body	Yes (true)	Form990ProvidedToGvrnBodyInd
Conflict Of Interest Policy	Yes (true)	ConflictOfInterestPolicyInd
Annual Disclosure Covered Prsn	Yes (true)	AnnualDisclosureCoveredPrsnInd
Regular Monitoring Enfrc	Yes (true)	RegularMonitoringEnfrcInd
Whistleblower Policy	Yes (true)	WhistleblowerPolicyInd
Document Retention Policy	Yes (true)	DocumentRetentionPolicyInd
Compensation Process CEO	Yes (true)	CompensationProcessCEOInd
Compensation Process Other	Yes (true)	CompensationProcessOtherInd
Investment In Joint Venture	Yes (true)	InvestmentInJointVentureInd
Written Policy Or Procedure	Yes (true)	WrittenPolicyOrProcedureInd
States Where Copy Of Return Is Fld	AL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AK	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AZ	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CO	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	DE	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	DC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	FL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	GA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	HI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	ID	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	IL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	IN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	IA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	LA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	ME	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MD	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MO	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NE	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NV	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NH	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NJ	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NM	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	ND	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OH	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OK	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	PA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	RI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	SC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	SD	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	TN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	TX	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	UT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	VT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	VA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WV	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WY	StatesWhereCopyOfReturnIsFldCd
Own Website	Yes (X)	OwnWebsiteInd
Upon Request	Yes (X)	UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Field	Value	IRS element (for citing)
Person	EMMA PANGILINAN-ROSALES	PersonNm
Phone	2124797550	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	200 VESEY STREET 28TH FLOOR	AddressLine1Txt
City	NEW YORK	CityNm
State Abbreviation	NY	StateAbbreviationCd
ZIP	10281	ZIPCd

Field	Value	IRS element (for citing)
Info In Schedule O Part VII	Yes (X)	InfoInScheduleOPartVIIInd

Form990 Part VII Section A Form990PartVIISectionAGrp (46 entries)

TitleTitleTxt	Average Hours Per WeekAverageHoursPerWeekRt	Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt	Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd	Reportable Comp From OrgReportableCompFromOrgAmt	Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt	Other CompensationOtherCompensationAmt	OfficerOfficerInd	Key EmployeeKeyEmployeeInd	Highest Compensated EmployeeHighestCompensatedEmployeeInd	Former Ofcr Director TrusteeFormerOfcrDirectorTrusteeInd
JEFF ADAMS FY19-21
BOARD MEMBER	3.0	0.0	Yes (X)	$0	$0	$0
MICHAEL ALTER FY19-21
BOARD MEMBER	3.0	0.0	Yes (X)	$0	$0	$0
BRANDON ARBITER FY18-20
BOARD MEMBER	3.0	0.0	Yes (X)	$0	$0	$0
NANETTE DETURK FY17-19
CHAIR, ADVOCACY	5.0	0.0	Yes (X)	$0	$0	$0
MICHELLE GRIFFIN FY17-19
CHAIR, DEVELOPMENT	5.0	0.0	Yes (X)	$0	$0	$0
STEPHEN NEWMAN MD FY17-19
BOARD MEMBER	3.0	0.0	Yes (X)	$0	$0	$0
RANDY ANDERSON FY18-20
BOARD MEMBER	3.0	0.0	Yes (X)	$0	$0	$0
TIMOTHY CLARK FY18-20
BOARD MEMBER	3.0	0.0	Yes (X)	$0	$0	$0
MARY ELIZABETH BUNZEL FY18-19
CHAIR, CHANCELLORS	5.0	0.0	Yes (X)	$0	$0	$0	Yes (X)
LISA REED FY18-20
BOARD MEMBER	3.0	0.0	Yes (X)	$0	$0	$0
MARVIN DAITCH FY19-21
BOARD MEMBER	3.0	0.0	Yes (X)	$0	$0	$0
MIKE NORONA FY19-21
BOARD MEMBER	3.0	0.0	Yes (X)	$0	$0	$0
MARGERY PERRY FY19-21
CHAIR, RESEARCH	5.0	0.0	Yes (X)	$0	$0	$0
LISA WALLACK FY19-21
CHAIR, NOMINATING	5.0	0.0	Yes (X)	$0	$0	$0	Yes (X)
SEAN DOHERTY FY17-19
CHAIR, JDRF T1D FUND LLC	5.0	0.0	Yes (X)	$0	$0	$0
PAUL HEATH FY17-19
BOARD MEMBER	3.0	0.0	Yes (X)	$0	$0	$0
KAREN JORDAN FY19-21
BOARD MEMBER	3.0	0.0	Yes (X)	$0	$0	$0
JOHN KAMPFE FY17-19
BOARD MEMBER	3.0	0.0	Yes (X)	$0	$0	$0
JEFF PLUMER FY19-21
BOARD VICE-CHAIR	10.0	0.0	Yes (X)	$0	$0	$0	Yes (X)
DOUG LOWENSTEIN FY19-21
BOARD MEMBER	3.0	0.0	Yes (X)	$0	$0	$0
DAYTON OGDEN FY17-19
BOARD MEMBER	3.0	0.0	Yes (X)	$0	$0	$0
ANGIE PLATT FY17-19
BOARD MEMBER	3.0	0.0	Yes (X)	$0	$0	$0
JERRY WISLER FY17-19
BOARD MEMBER	3.0	0.0	Yes (X)	$0	$0	$0
KAREY L WITTY FY17-19
CHAIR, AUDIT	5.0	0.0	Yes (X)	$0	$0	$0
GRANT BEARD FY18-20
CHAIR, FINANCE	5.0	0.0	Yes (X)	$0	$0	$0	Yes (X)
STEVEN DAVIS FY18-20
BOARD MEMBER	3.0	0.0	Yes (X)	$0	$0	$0
CATHY BAIER FY18-20
BOARD MEMBER	3.0	0.0	Yes (X)	$0	$0	$0
JENNIFER BENNETT FY18-20
BOARD MEMBER	3.0	0.0	Yes (X)	$0	$0	$0
JOE LACHER FY18-20
CHAIR, TALENT & COMPENSATION	5.0	0.0	Yes (X)	$0	$0	$0
KIM ROOSEVELT FY18-20
BOARD MEMBER	5.0	0.0	Yes (X)	$0	$0	$0
JENNIFER SCHNEIDER FY19-21
BOARD MEMBER	3.0	0.0	Yes (X)	$0	$0	$0
MATT VAREY FY18-20
BOARD MEMBER	3.0	0.0	Yes (X)	$0	$0	$0
ELLEN LEAKE FY17-19
CHAIRMAN OF THE BOARD	20.0	0.0	Yes (X)	$0	$0	$0	Yes (X)
MICHAEL SOPER FY19-21
BOARD MEMBER	3.0	0.0	Yes (X)	$0	$0	$0
CHRISTOPHER TURNER FY18-20
CHAIR, INVESTMENTS	5.0	0.0	Yes (X)	$0	$0	$0
DEREK RAPP
PRESIDENT AND CEO	50.0	0.0		$800,000	$0	$49,089	Yes (X)
SANDRA HIJIKATA
CHIEF DEV OFFICER & ASST. SECY	50.0	0.0		$443,750	$0	$21,194	Yes (X)
JILL CLARK
CHIEF OF STAFF & ASST. SECY	50.0	0.0		$353,603	$0	$19,251	Yes (X)
JOANNE MARTZ BEGAN 1018
CFO	50.0	0.0		$79,982	$0	$1,371	Yes (X)
JONATHAN R BEHR
MANAGING DIRECTOR JDRF-T1D FND	50.0	0.0		$499,333	$0	$51,654		Yes (X)
AARON KOWALSKI
CHIEF MISSION OFFICER	50.0	0.0		$502,667	$0	$48,716			Yes (X)
ALISA NORRIS
CHIEF MARKETING OFFICER	50.0	0.0		$403,200	$0	$53,539			Yes (X)
JULIA GREENSTEIN
VP RESEARCH	50.0	0.0		$319,567	$0	$14,996			Yes (X)
SUSAN YUN
CHIEF PEOPLE OFFICER	50.0	0.0		$353,333	$0	$18,647			Yes (X)
CYNTHIA RICE
SVP ADVOCACY AND POLICY	50.0	0.0		$342,405	$0	$49,089			Yes (X)
MARK GREENE THRU 518
FORMER CFO & ASST. TRES	0.0	0.0		$351,877	$0	$4,694				Yes (X)

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	$4,449,717	TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org	$0	TotReportableCompRltdOrgAmt
Total Other Compensation	$332,240	TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K	167	IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed	Yes (true)	FormerOfcrEmployeesListedInd
Total Comp Greater Than150 K	Yes (true)	TotalCompGreaterThan150KInd
Compensation From Other Srcs	false	CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1Txt	CityContractorAddress/USAddress/CityNm	State AbbreviationContractorAddress/USAddress/StateAbbreviationCd	ZIPContractorAddress/USAddress/ZIPCd	ServicesServicesDesc	CompensationCompensationAmt
10UP LLC
2765 CARRADALE DR	ROSEVILLE	CA	95661	WEB DEVELOPMENT	$422,794
CDS GLOBAL
1901 BELL AVE	DES MOINES	IA	50315	3RD PARTY LOCK BOX	$386,914
BLUE STATE DIGITAL
101 AVE OF THE AMERICAS	NEW YORK	NY	10013	DIGITAL CONSULTING	$1,918,746
AKA ENTERPRISE SOLUTIONS
875 SIXTH AVE 20th FLOOR	NEW YORK	NY	10001	EPM IMPLEMENTATION	$891,856
CONNECTIONS MEDIA LLC
1728 14th St NW 4309	WASHINGTON	DC	20009	MARKETING CONSULTING	$319,725

Field	Value	IRS element (for citing)
Cntrct Rcvd Greater Than100 K	23	CntrctRcvdGreaterThan100KCnt
Federated Campaigns	$4,178,999	FederatedCampaignsAmt
Fundraising	$130,162,354	FundraisingAmt
All Other Contributions	$81,317,658	AllOtherContributionsAmt
Noncash Contributions	$21,299,838	NoncashContributionsAmt
Total Contributions	$215,659,011	TotalContributionsAmt
Total Program Service Revenue	$0	TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$2,663,884	TotalRevenueColumnAmt
Unrelated Business Revenue	$225,709	UnrelatedBusinessRevenueAmt
Exclusion	$2,438,175	ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Royalties Revenue RoyaltiesRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Rental Income Or Loss RentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Real	$0	RealAmt
Personal	$0	PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

Field	Value	IRS element (for citing)
Securities	$53,440,349	SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

Field	Value	IRS element (for citing)
Securities	$36,130,924	SecuritiesAmt

Gain Or Loss GainOrLossGrp

Field	Value	IRS element (for citing)
Securities	$17,309,425	SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$17,309,425	TotalRevenueColumnAmt
Exclusion	$17,309,425	ExclusionAmt

Field	Value	IRS element (for citing)
Fundraising Gross Income	$31,012,479	FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event	$130,162,354	ContriRptFundraisingEventAmt
Fundraising Direct Expenses	$31,012,479	FundraisingDirectExpensesAmt
Gaming Gross Income	$1,471,466	GamingGrossIncomeAmt
Gaming Direct Expenses	$87,803	GamingDirectExpensesAmt

Net Income From Gaming NetIncomeFromGamingGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$1,383,663	TotalRevenueColumnAmt
Exclusion	$1,383,663	ExclusionAmt

Field	Value	IRS element (for citing)
Gross Sales Of Inventory	$0	GrossSalesOfInventoryAmt
Cost Of Goods Sold	$0	CostOfGoodsSoldAmt

Net Income Or Loss NetIncomeOrLossGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Other Revenue Misc OtherRevenueMiscGrp

Field	Value	IRS element (for citing)
Desc	MISC REVENUE	Desc
Business	900099	BusinessCd
Total Revenue Column	$2,313,482	TotalRevenueColumnAmt
Exclusion	$2,313,482	ExclusionAmt

Field	Value	IRS element (for citing)
Other Revenue Total	$2,313,482	OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$239,329,465	TotalRevenueColumnAmt
Unrelated Business Revenue	$225,709	UnrelatedBusinessRevenueAmt
Exclusion	$23,444,745	ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

Field	Value	IRS element (for citing)
Total	$58,486,700	TotalAmt
Program Services	$58,486,700	ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Foreign Grants ForeignGrantsGrp

Field	Value	IRS element (for citing)
Total	$30,650,791	TotalAmt
Program Services	$30,650,791	ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

Field	Value	IRS element (for citing)
Total	$2,675,800	TotalAmt
Program Services	$1,605,480	ProgramServicesAmt
Management And General	$374,612	ManagementAndGeneralAmt
Fundraising	$695,708	FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

Field	Value	IRS element (for citing)
Total	$61,896,753	TotalAmt
Program Services	$35,871,461	ProgramServicesAmt
Management And General	$10,947,789	ManagementAndGeneralAmt
Fundraising	$15,077,503	FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

Field	Value	IRS element (for citing)
Total	$1,673,604	TotalAmt
Program Services	$962,879	ProgramServicesAmt
Management And General	$291,070	ManagementAndGeneralAmt
Fundraising	$419,655	FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

Field	Value	IRS element (for citing)
Total	$9,489,943	TotalAmt
Program Services	$5,379,325	ProgramServicesAmt
Management And General	$1,630,105	ManagementAndGeneralAmt
Fundraising	$2,480,513	FundraisingAmt

Payroll Taxes PayrollTaxesGrp

Field	Value	IRS element (for citing)
Total	$4,573,085	TotalAmt
Program Services	$2,583,998	ProgramServicesAmt
Management And General	$851,259	ManagementAndGeneralAmt
Fundraising	$1,137,828	FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

Field	Value	IRS element (for citing)
Total	$3,314,924	TotalAmt
Program Services	$2,343,258	ProgramServicesAmt
Management And General	$396,780	ManagementAndGeneralAmt
Fundraising	$574,886	FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

Field	Value	IRS element (for citing)
Total	$624,888	TotalAmt
Program Services	$382,742	ProgramServicesAmt
Management And General	$174,440	ManagementAndGeneralAmt
Fundraising	$67,706	FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

Field	Value	IRS element (for citing)
Total	$235,095	TotalAmt
Program Services	$95	ProgramServicesAmt
Management And General	$235,000	ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

Field	Value	IRS element (for citing)
Total	$649,491	TotalAmt
Program Services	$649,491	ProgramServicesAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

Field	Value	IRS element (for citing)
Total	$339,984	TotalAmt
Fundraising	$339,984	FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

Field	Value	IRS element (for citing)
Total	$216,069	TotalAmt
Management And General	$216,069	ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

Field	Value	IRS element (for citing)
Total	$2,766,436	TotalAmt
Program Services	$1,749,921	ProgramServicesAmt
Management And General	$355,780	ManagementAndGeneralAmt
Fundraising	$660,735	FundraisingAmt

Advertising AdvertisingGrp

Field	Value	IRS element (for citing)
Total	$4,963,685	TotalAmt
Program Services	$2,714,384	ProgramServicesAmt
Management And General	$312,422	ManagementAndGeneralAmt
Fundraising	$1,936,879	FundraisingAmt

Office Expenses OfficeExpensesGrp

Field	Value	IRS element (for citing)
Total	$1,954,418	TotalAmt
Program Services	$873,263	ProgramServicesAmt
Management And General	$332,251	ManagementAndGeneralAmt
Fundraising	$748,904	FundraisingAmt

Information Technology InformationTechnologyGrp

Field	Value	IRS element (for citing)
Total	$5,710,525	TotalAmt
Program Services	$2,395,705	ProgramServicesAmt
Management And General	$1,552,447	ManagementAndGeneralAmt
Fundraising	$1,762,373	FundraisingAmt

Royalties RoyaltiesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Occupancy OccupancyGrp

Field	Value	IRS element (for citing)
Total	$7,088,084	TotalAmt
Program Services	$3,936,420	ProgramServicesAmt
Management And General	$1,208,905	ManagementAndGeneralAmt
Fundraising	$1,942,759	FundraisingAmt

Travel TravelGrp

Field	Value	IRS element (for citing)
Total	$3,036,195	TotalAmt
Program Services	$1,415,332	ProgramServicesAmt
Management And General	$831,452	ManagementAndGeneralAmt
Fundraising	$789,411	FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Conferences Meetings ConferencesMeetingsGrp

Field	Value	IRS element (for citing)
Total	$1,394,302	TotalAmt
Program Services	$837,454	ProgramServicesAmt
Management And General	$194,329	ManagementAndGeneralAmt
Fundraising	$362,519	FundraisingAmt

Interest InterestGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Payments To Affiliates PaymentsToAffiliatesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Depreciation Depletion DepreciationDepletionGrp

Field	Value	IRS element (for citing)
Total	$3,872,196	TotalAmt
Program Services	$1,357,225	ProgramServicesAmt
Management And General	$836,085	ManagementAndGeneralAmt
Fundraising	$1,678,886	FundraisingAmt

Insurance InsuranceGrp

Field	Value	IRS element (for citing)
Total	$513,638	TotalAmt
Program Services	$312,292	ProgramServicesAmt
Management And General	$88,859	ManagementAndGeneralAmt
Fundraising	$112,487	FundraisingAmt

Other Expenses OtherExpensesGrp (3 entries)

DescDesc	TotalTotalAmt	Program ServicesProgramServicesAmt	Management And GeneralManagementAndGeneralAmt	FundraisingFundraisingAmt
OUTREACH EXPENSES	$3,629,031	$3,285,588	$251,150	$92,293
DUES & FEES	$1,518,853	$887,209	$265,562	$366,082
OTHER MISC EXPENSES	$1,295,562	$868,796	$171,942	$254,824

Total Functional Expenses TotalFunctionalExpensesGrp

Field	Value	IRS element (for citing)
Total	$212,570,052	TotalAmt
Program Services	$159,549,809	ProgramServicesAmt
Management And General	$21,518,308	ManagementAndGeneralAmt
Fundraising	$31,501,935	FundraisingAmt

Field	Value	IRS element (for citing)
Joint Costs	Yes (X)	JointCostsInd

Total Joint Costs TotalJointCostsGrp

Field	Value	IRS element (for citing)
Total	$2,052,275	TotalAmt
Program Services	$525,773	ProgramServicesAmt
Management And General	$0	ManagementAndGeneralAmt
Fundraising	$1,526,502	FundraisingAmt

Field	Value	IRS element (for citing)
Info In Schedule O Part X	Yes (X)	InfoInScheduleOPartXInd

Cash Non Interest Bearing CashNonInterestBearingGrp

Field	Value	IRS element (for citing)
BOY	$14,717,083	BOYAmt
EOY	$19,125,818	EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

Field	Value	IRS element (for citing)
BOY	$39,185,381	BOYAmt
EOY	$36,566,833	EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$29,143,990	BOYAmt
EOY	$30,267,097	EOYAmt

Accounts Receivable AccountsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$21,529,716	BOYAmt
EOY	$20,525,959	EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

Field	Value	IRS element (for citing)
BOY	$1,500,000	BOYAmt
EOY	$6,720,000	EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

Field	Value	IRS element (for citing)
BOY	$5,991,334	BOYAmt
EOY	$6,103,129	EOYAmt

Field	Value	IRS element (for citing)
Land Bldg Equip Cost Or Other Bss	$28,323,770	LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec	$22,428,738	LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

Field	Value	IRS element (for citing)
BOY	$7,329,209	BOYAmt
EOY	$5,895,032	EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

Field	Value	IRS element (for citing)
BOY	$65,033,089	BOYAmt
EOY	$93,573,878	EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

Field	Value	IRS element (for citing)
BOY	$30,662,349	BOYAmt
EOY	$4,213,073	EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

Field	Value	IRS element (for citing)
BOY	$11,261,030	BOYAmt
EOY	$21,443,947	EOYAmt

Intangible Assets IntangibleAssetsGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Other Assets Total OtherAssetsTotalGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Total Assets TotalAssetsGrp

Field	Value	IRS element (for citing)
BOY	$226,353,181	BOYAmt
EOY	$244,434,766	EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

Field	Value	IRS element (for citing)
BOY	$22,350,808	BOYAmt
EOY	$16,774,462	EOYAmt

Grants Payable GrantsPayableGrp

Field	Value	IRS element (for citing)
BOY	$94,919,621	BOYAmt
EOY	$100,065,608	EOYAmt

Deferred Revenue DeferredRevenueGrp

Field	Value	IRS element (for citing)
BOY	$10,051,979	BOYAmt
EOY	$9,232,753	EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Other Liabilities OtherLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$2,625,288	BOYAmt
EOY	$2,560,463	EOYAmt

Total Liabilities TotalLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$129,947,696	BOYAmt
EOY	$128,633,286	EOYAmt

Field	Value	IRS element (for citing)
Organization Follows SFAS117	Yes (X)	OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$57,009,483	BOYAmt
EOY	$76,838,325	EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$31,828,002	BOYAmt
EOY	$31,075,322	EOYAmt

Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$7,568,000	BOYAmt
EOY	$7,887,833	EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$96,405,485	BOYAmt
EOY	$115,801,480	EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$226,353,181	BOYAmt
EOY	$244,434,766	EOYAmt

Field	Value	IRS element (for citing)
Reconcilation Revenue Expnss	$26,759,413	ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst	-$7,363,418	NetUnrlzdGainsLossesInvstAmt
Method Of Accounting Accrual	Yes (X)	MethodOfAccountingAccrualInd
Accountant Compile Or Review	false	AccountantCompileOrReviewInd
FS Audited	Yes (true)	FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

Field	Value	IRS element (for citing)
Consolidated Basis Fincl Stmt	Yes (X)	ConsolidatedBasisFinclStmtInd

Field	Value	IRS element (for citing)
Audit Committee	Yes (true)	AuditCommitteeInd
Federal Grant Audit Required	false	FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Public Organization170	Yes (X)	PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$198,918,214	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$196,804,267	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$199,896,852	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$219,968,105	CurrentTaxYearMinus1YearAmt
Current Tax Year	$215,659,011	CurrentTaxYearAmt
Total	$1,031,246,449	TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$198,918,214	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$196,804,267	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$199,896,852	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$219,968,105	CurrentTaxYearMinus1YearAmt
Current Tax Year	$215,659,011	CurrentTaxYearAmt
Total	$1,031,246,449	TotalAmt

Field	Value	IRS element (for citing)
Substantial Contributors Tot	$2,167,760	SubstantialContributorsTotAmt
Public Support Total170	$1,029,078,689	PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$987,577	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$465,379	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$548,825	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$1,309,523	CurrentTaxYearMinus1YearAmt
Current Tax Year	$2,439,225	CurrentTaxYearAmt
Total	$5,750,529	TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$2,516	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$112,437	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$33,150	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$138,747	CurrentTaxYearMinus1YearAmt
Current Tax Year	$186,965	CurrentTaxYearAmt
Total	$473,815	TotalAmt

Other Income170 OtherIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$256,146	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$94,769	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$283,014	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$1,793,044	CurrentTaxYearMinus1YearAmt
Current Tax Year	$2,313,482	CurrentTaxYearAmt
Total	$4,740,455	TotalAmt

Field	Value	IRS element (for citing)
Total Support	$1,042,211,248	TotalSupportAmt
Public Support CY170	0.98740	PublicSupportCY170Pct
Public Support PY170	0.98519	PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170	Yes (X)	ThirtyThrPctSuprtTestsCY170Ind

Schedule C IRS990ScheduleC

Field	Value	IRS element (for citing)
Total Grassroots Lobbying		TotalGrassrootsLobbyingGrp
Total Direct Lobbying		TotalDirectLobbyingGrp
Total Lobbying Expend		TotalLobbyingExpendGrp
Other Exempt Purpose Expend		OtherExemptPurposeExpendGrp
Total Exempt Purpose Expend		TotalExemptPurposeExpendGrp
Lobbying Nontaxable Amount		LobbyingNontaxableAmountGrp
Grassroots Nontaxable		GrassrootsNontaxableGrp
Tot Lbbyng Grassroot Mns Non Tx		TotLbbyngGrassrootMnsNonTxGrp
Tot Lbby Expend Mns Lbbyng Non Tx		TotLbbyExpendMnsLbbyngNonTxGrp
Form4720 Filed	false	Form4720FiledInd
Volunteers	Yes (true)	VolunteersInd
Paid Staff Or Management	Yes (true)	PaidStaffOrManagementInd
Media Advertisements	false	MediaAdvertisementsInd
Mailings Members	Yes (true)	MailingsMembersInd
Mailings Members	$11,027	MailingsMembersAmt
Publications Or Broadcast	Yes (true)	PublicationsOrBroadcastInd
Publications Or Broadcast	$73,148	PublicationsOrBroadcastAmt
Grants Other Organizations	Yes (true)	GrantsOtherOrganizationsInd
Grants Other Organizations	$5,945	GrantsOtherOrganizationsAmt
Direct Contact Legislators	Yes (true)	DirectContactLegislatorsInd
Direct Contact Legislators	$663,113	DirectContactLegislatorsAmt
Rallies Demonstrations	Yes (true)	RalliesDemonstrationsInd
Rallies Demonstrations	$121,407	RalliesDemonstrationsAmt
Other Activities	false	OtherActivitiesInd
Total Lobbying Expenditures	$874,640	TotalLobbyingExpendituresAmt
Not Described Section501c3	false	NotDescribedSection501c3Ind

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	JDRF LOBBYING ACTIVITIES	FormAndLineReferenceDesc
Explanation	FORM 990- SCH-C- GENERAL STATEMENT OF ACTIVITIES JDRF is the leading global organization funding type 1 diabetes (T1D) research, focused on curing T1D and improving lives. JDRF's advocacy includes lobbying activity to ensure Congress continues to invest in critically important medical research and puts in place policies to advance development and access to therapies to cure T1D and help people stay as healthy as possible until that day. JDRF has been instrumental in securing the renewal of the Special Diabetes Program, which provides $150MM annually for T1D research at the National Institutes of Health. JDRF staff and volunteers communicate with government officials through email, phone calls, and meetings, to educate them on issues and encourage the advancement of legislation.	ExplanationTxt

Schedule D IRS990ScheduleD

Field	Value	IRS element (for citing)
Art Public Exhibition Amounts		ArtPublicExhibitionAmountsGrp
Held Works Art		HeldWorksArtGrp

CY Endwmt Fund CYEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$7,567,601	BeginningYearBalanceAmt
Contributions	$221,441	ContributionsAmt
Investment Earnings Or Losses	$102,034	InvestmentEarningsOrLossesAmt
Other Expenditures	$3,243	OtherExpendituresAmt
End Year Balance	$7,887,833	EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$7,341,367	BeginningYearBalanceAmt
Investment Earnings Or Losses	$268,304	InvestmentEarningsOrLossesAmt
Other Expenditures	$42,070	OtherExpendituresAmt
End Year Balance	$7,567,601	EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$7,176,427	BeginningYearBalanceAmt
Investment Earnings Or Losses	$367,446	InvestmentEarningsOrLossesAmt
Other Expenditures	$202,506	OtherExpendituresAmt
End Year Balance	$7,341,367	EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$7,141,514	BeginningYearBalanceAmt
Investment Earnings Or Losses	$37,913	InvestmentEarningsOrLossesAmt
Other Expenditures	$3,000	OtherExpendituresAmt
End Year Balance	$7,176,427	EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$7,426,222	BeginningYearBalanceAmt
Investment Earnings Or Losses	$11,292	InvestmentEarningsOrLossesAmt
Other Expenditures	$296,000	OtherExpendituresAmt
End Year Balance	$7,141,514	EndYearBalanceAmt

Field	Value	IRS element (for citing)
Prmnnt Endowment Balance EOY	1.00000	PrmnntEndowmentBalanceEOYPct
Endowments Held Unrelated Org	false	EndowmentsHeldUnrelatedOrgInd
Endowments Held Related Org	false	EndowmentsHeldRelatedOrgInd
Land		LandGrp
Buildings		BuildingsGrp

Leasehold Improvements LeaseholdImprovementsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$4,935,841	OtherCostOrOtherBasisAmt
Depreciation	$4,437,766	DepreciationAmt
Book Value	$498,075	BookValueAmt

Equipment EquipmentGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$23,387,929	OtherCostOrOtherBasisAmt
Depreciation	$17,990,972	DepreciationAmt
Book Value	$5,396,957	BookValueAmt

Field	Value	IRS element (for citing)
Other Land Buildings		OtherLandBuildingsGrp
Total Book Value Land Buildings	$5,895,032	TotalBookValueLandBuildingsAmt

Invst Program Related Org InvstProgramRelatedOrgGrp

Field	Value	IRS element (for citing)
Desc	T1D FUND PROGRAM RELATED INVES	Desc
Book Value	$21,443,947	BookValueAmt
Method Valuation	F	MethodValuationCd

Field	Value	IRS element (for citing)
Total Book Value Program Rltd	$21,443,947	TotalBookValueProgramRltdAmt
Federal Income Tax Liability	$0	FederalIncomeTaxLiabilityAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

Field	Value	IRS element (for citing)
Desc	SPLIT INTEREST CHRT RMDR TRUST	Desc
Amt	$2,560,463	Amt

Field	Value	IRS element (for citing)
Total Liability	$2,560,463	TotalLiabilityAmt
Footnote Text	Yes (X)	FootnoteTextInd
Total Rev Etc Audited Fincl Stmt	$231,749,978	TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst	-$7,363,418	NetUnrealizedGainsInvstAmt
Other Revenue	-$216,069	OtherRevenueAmt
Revenue Not Reported	-$7,579,487	RevenueNotReportedAmt
Revenue Subtotal	$239,329,465	RevenueSubtotalAmt
Total Revenue Per Form990	$239,329,465	TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt	$212,353,983	TotExpnsEtcAuditedFinclStmtAmt
Expenses Subtotal	$212,353,983	ExpensesSubtotalAmt
Investment Expenses Not Incld2	$216,069	InvestmentExpensesNotIncld2Amt
Expenses Not Rpt Fincl Stmt	$216,069	ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990	$212,570,052	TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDesc

ExplanationExplanationTxt

ORGANIZATION'S ENDOWMENT FUNDS

FORM 990, PART X, LINE 28 & 29 & SCH D, PART V THE ORGANIZATION UTILIZES EARNINGS ON ENDOWMENT FUNDS IN THE MANNER SPECIFIED BY THE DONOR AND/OR FOR SUPPORTING THE ORGANIZATIONS GENERAL EXEMPT PURPOSE.

UNCERTAIN TAX POSITIONS

990 SCH-D, PART X, LINE 2 JDRF IS A NOT FOR PROFIT ORGANIZATION EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501 (C) (3) OF THE INTERNAL REVENUE CODE AND IS ORGANIZED UNDER THE LAWS OF THE COMMONWEALTH OF PENNSYLVANIA. THE EFFECT OF INCOME INCOME TAX POSITIONS IS RECOGNIZED ONLY IF THE POSITIONS ARE MORE LIKELY THAN NOT OF BEING SUSTAINED. INCOME GENERATED FROM ACTIVITIES UNRELATED TO JDRF'S EXEMPT PURPOSE IS SUBJECT TO TAX UNDER INTERNAL REVENUE CODE SECTION 511. UNRELATED BUSINESS INCOME TAX LIABILITY WAS INSIGNIFICANT FOR THE YEARS ENDING JUNE 30, 2019 AND 2018.

Schedule F IRS990ScheduleF

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (true)	GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (6 entries)

RegionRegionTxt	Type Of Activities ConductedTypeOfActivitiesConductedTxt	Specific Services ProvidedSpecificServicesProvidedTxt	Region Total ExpendituresRegionTotalExpendituresAmt	OfficesOfficesCnt	EmployeeEmployeeCnt
North America	Grantmaking	RESEARCH GRANTS	$4,958,404
Europe (Including Iceland and Greenland)	Grantmaking	RESEARCH GRANTS	$17,529,266
Middle East and North Africa	Grantmaking	RESEARCH GRANTS	$890,206
East Asia and the Pacific	Grantmaking	RESEARCH GRANTS	$7,272,915
Europe (Including Iceland and Greenland)	Program Services	RESEARCH SUPPORT	$532,586	2	2
Central America and the Caribbean	Investments	INVESTMENTS	$33,187

Field	Value	IRS element (for citing)
Subtotal Offices	2	SubtotalOfficesCnt
Subtotal Employees	2	SubtotalEmployeesCnt
Total Office	2	TotalOfficeCnt
Total Employee	2	TotalEmployeeCnt
Subtotal Spent	$31,216,564	SubtotalSpentAmt
Total Spent	$31,216,564	TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (80 entries)

RegionRegionTxt	Purpose Of GrantPurposeOfGrantTxt	Cash GrantCashGrantAmt	Manner Of Cash DisbursementMannerOfCashDisbursementTxt	Description Of Non Cash AsstDescriptionOfNonCashAsstTxt	Valuation Method UsedValuationMethodUsedDesc
Europe (Including Iceland and Greenland)	IMMUNE THERAPIES	$40,000	CHECK/WIRE	N/A	N/A
East Asia and the Pacific		$120,917	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)	IMMUNE THERAPIES	$225,155	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)		$1,282,048	CHECK/WIRE	N/A	N/A
Middle East and North Africa		$319,706	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)		$899,045	CHECK/WIRE	N/A	N/A
East Asia and the Pacific		$579,500	CHECK/WIRE	N/A	N/A
East Asia and the Pacific		$150,000	CHECK/WIRE	N/A	N/A
North America	IMMUNE THERAPIES	$58,716	CHECK/WIRE	N/A	N/A
East Asia and the Pacific		$200,000	CHECK/WIRE	N/A	N/A
North America		$1,082,089	CHECK/WIRE	N/A	N/A
North America		$1,442,432	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)	IMMUNE THERAPIES	$599,813	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)		$385,109	CHECK/WIRE	N/A	N/A
North America		$220,285	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)		$150,000	CHECK/WIRE	N/A	N/A
East Asia and the Pacific		$360,000	CHECK/WIRE	N/A	N/A
North America	IMMUNE THERAPIES	$249,714	CHECK/WIRE	N/A	N/A
North America	IMMUNE THERAPIES	$435,597	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)	IMMUNE THERAPIES	$247,317	CHECK/WIRE	N/A	N/A
East Asia and the Pacific		$975,505	CHECK/WIRE	N/A	N/A
North America		$66,900	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)	IMMUNE THERAPIES	$1,342,769	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)	IMMUNE THERAPIES	$313,508	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)		$678,455	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)		$249,976	CHECK/WIRE	N/A	N/A
North America		$341,953	CHECK/WIRE	N/A	N/A
East Asia and the Pacific	ARTIFICIAL PANCREAS	$250,000	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)		$185,500	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)		$1,191,662	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)	IMMUNE THEPAPIES	$346,739	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)		$350,000	CHECK/WIRE	N/A	N/A
Middle East and North Africa	IMMUNE THERAPIES	$34,985	CHECK/WIRE	N/A	N/A
Middle East and North Africa	IMMUNE THERAPIES	$150,335	CHECK/WIRE	N/A	N/A
East Asia and the Pacific		$250,000	CHECK/WIRE	N/A	N/A
North America	IMMUNE THERAPIES	$400,000	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)		$1,401,418	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)	BETA CELL	$125,000	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)	IMMUNE THERAPIES	$266,343	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)	IMMUNE THERAPIES	$118,496	CHECK/WIRE	N/A	N/A
East Asia and the Pacific	IMMUNE THERAPIES	$618,750	CHECK/WIRE	N/A	N/A
East Asia and the Pacific	IMMUNE THERAPIES	$938,315	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)	IMMUNE THERAPIES	$72,589	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)	BETA CELL	$225,000	CHECK/WIRE	N/A	N/A
East Asia and the Pacific	IMMUNE THERAPIES	$710,572	CHECK/WIRE	N/A	N/A
North America	IMMUNE THERAPIES	$429,400	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)	IMMUNE THERAPIES	$406,488	CHECK/WIRE	N/A	N/A
East Asia and the Pacific	IMMUNE THERAPIES	$249,466	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)	IMMUNE THERAPIES	$83,325	CHECK/WIRE	N/A	N/A
East Asia and the Pacific	IMMUNE THERAPIES	$450,000	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)	IMMUNE THERAPIES	$350,000	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)	IMMUNE THERAPIES	$410,738	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)	IMMUNE THERAPIES	$349,560	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)	IMMUNE THERAPIES	$109,771	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)	IMMUNE THERAPIES	$92,273	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)	IMMUNE THERAPIES	$346,832	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)	IMMUNE THERAPIES	$174,790	CHECK/WIRE	N/A	N/A
North America		$250,000	CHECK/WIRE	N/A	N/A
East Asia and the Pacific		$600,000	CHECK/WIRE	N/A	N/A
East Asia and the Pacific		$109,945	CHECK/WIRE	N/A	N/A
East Asia and the Pacific		$109,945	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)		$1,025,000	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)		$104,413	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)		$374,799	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)		$197,964	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)		$300,000	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)		$259,735	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)		$199,928	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)		$130,000	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)		$95,000	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)		$350,000	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)		$563,368	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)		$143,920	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)	ARTIFICIAL PANCREAS	$50,000	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)		$641,505	CHECK/WIRE	N/A	N/A
East Asia and the Pacific		$600,000	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)	BETA CELL	$250,000	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)		$248,724	CHECK/WIRE	N/A	N/A
Middle East and North Africa		$385,180	CHECK/WIRE	N/A	N/A
Europe (Including Iceland and Greenland)	BETA CELL	$190,017	CHECK/WIRE	N/A	N/A

Field	Value	IRS element (for citing)
Total501c3 Org	61	Total501c3OrgCnt
Total Other Org	19	TotalOtherOrgCnt
Transfer To Foreign Corp	Yes (true)	TransferToForeignCorpInd
Interest In Foreign Trust	false	InterestInForeignTrustInd
Foreign Corp Ownership	Yes (true)	ForeignCorpOwnershipInd
Passive Foreign Investmest Co	Yes (true)	PassiveForeignInvestmestCoInd
Foreign Partnership	false	ForeignPartnershipInd
Boycott Countries	false	BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	GRANT MONITORING PROCEDURES	FormAndLineReferenceDesc
Explanation	SCH-F PART I LINE 2 Research grants are awarded by JDRF with the support of JDRF's Research Committee comprised of "JDRF Board members and other volunteers" following the recommendations of an in-house team of professional scientific staff and with input from external scientific reviewers and patient advocates. The review process includes the following criteria: (1) The scientific merit of the proposed research outlined in a grant application and (2) The relationship of the proposed research to JDRF's goal to cure, prevent and treat T1D and its complications. The scientific research team and grant administration staff maintain close contact with grantees, providing advice and evaluation, reviewing progress reports, reviewing research expenditures versus agreed budgets, and helping disseminate research results.	ExplanationTxt

Schedule G IRS990ScheduleG

Field	Value	IRS element (for citing)
Mail Solicitations	Yes (X)	MailSolicitationsInd
Email Solicitations	Yes (X)	EmailSolicitationsInd
Solicitation Of Non Govt Grants	Yes (X)	SolicitationOfNonGovtGrantsInd
Solicitation Of Govt Grants	Yes (X)	SolicitationOfGovtGrantsInd
Special Fundraising Events	Yes (X)	SpecialFundraisingEventsInd
Agrmt Prof Fundraising Acty	Yes (true)	AgrmtProfFundraisingActyInd

Fundraiser Activity Info FundraiserActivityInfoGrp

Field	Value	IRS element (for citing)
Person	INSURANCE AUTO AUCTIONS LLC	PersonNm

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	TWO WESTBROOK CORORATE CENTER SUIT	AddressLine1Txt
City	WESTCHESTER	CityNm
State Abbreviation	IL	StateAbbreviationCd
ZIP	60154	ZIPCd

Field	Value	IRS element (for citing)
Activity	CAR DONATION	ActivityTxt
Fundraiser Control Of Funds	Yes (true)	FundraiserControlOfFundsInd
Gross Receipts	$261,400	GrossReceiptsAmt
Retained By Contractor	$107,183	RetainedByContractorAmt
Net To Organization	$154,217	NetToOrganizationAmt

Field	Value	IRS element (for citing)
Total Gross Receipts	$261,400	TotalGrossReceiptsAmt
Total Retained By Contractors	$107,183	TotalRetainedByContractorsAmt
Total Net To Organization	$154,217	TotalNetToOrganizationAmt
Licensed States	AL	LicensedStatesCd
Licensed States	AK	LicensedStatesCd
Licensed States	AZ	LicensedStatesCd
Licensed States	AR	LicensedStatesCd
Licensed States	CA	LicensedStatesCd
Licensed States	CO	LicensedStatesCd
Licensed States	CT	LicensedStatesCd
Licensed States	DE	LicensedStatesCd
Licensed States	DC	LicensedStatesCd
Licensed States	FL	LicensedStatesCd
Licensed States	GA	LicensedStatesCd
Licensed States	HI	LicensedStatesCd
Licensed States	ID	LicensedStatesCd
Licensed States	IL	LicensedStatesCd
Licensed States	IN	LicensedStatesCd
Licensed States	IA	LicensedStatesCd
Licensed States	KS	LicensedStatesCd
Licensed States	KY	LicensedStatesCd
Licensed States	LA	LicensedStatesCd
Licensed States	ME	LicensedStatesCd
Licensed States	MD	LicensedStatesCd
Licensed States	MA	LicensedStatesCd
Licensed States	MI	LicensedStatesCd
Licensed States	MN	LicensedStatesCd
Licensed States	MS	LicensedStatesCd
Licensed States	MO	LicensedStatesCd
Licensed States	NE	LicensedStatesCd
Licensed States	NV	LicensedStatesCd
Licensed States	NH	LicensedStatesCd
Licensed States	NJ	LicensedStatesCd
Licensed States	NM	LicensedStatesCd
Licensed States	NY	LicensedStatesCd
Licensed States	NC	LicensedStatesCd
Licensed States	ND	LicensedStatesCd
Licensed States	OH	LicensedStatesCd
Licensed States	OK	LicensedStatesCd
Licensed States	OR	LicensedStatesCd
Licensed States	PA	LicensedStatesCd
Licensed States	RI	LicensedStatesCd
Licensed States	SC	LicensedStatesCd
Licensed States	SD	LicensedStatesCd
Licensed States	TN	LicensedStatesCd
Licensed States	TX	LicensedStatesCd
Licensed States	UT	LicensedStatesCd
Licensed States	VT	LicensedStatesCd
Licensed States	VA	LicensedStatesCd
Licensed States	WA	LicensedStatesCd
Licensed States	WV	LicensedStatesCd
Licensed States	WI	LicensedStatesCd
Licensed States	WY	LicensedStatesCd

Fundraising Event Information FundraisingEventInformationGrp

Field	Value	IRS element (for citing)
Event1	ILLINOIS GALA	Event1Nm
Gross Receipts Event1	$5,758,207	GrossReceiptsEvent1Amt
Charitable Contri Event1	$4,870,051	CharitableContriEvent1Amt
Gross Revenue Event1	$888,156	GrossRevenueEvent1Amt
Rent Facility Costs Event1	$39,988	RentFacilityCostsEvent1Amt
Food And Beverage Event1	$342,765	FoodAndBeverageEvent1Amt
Entertainment Event1	$374,444	EntertainmentEvent1Amt
Other Direct Expenses Event1	$130,959	OtherDirectExpensesEvent1Amt
Event2	NORTHWEST GALA	Event2Nm
Gross Receipts Event2	$3,352,228	GrossReceiptsEvent2Amt
Charitable Contri Event2	$2,408,464	CharitableContriEvent2Amt
Gross Revenue Event2	$943,764	GrossRevenueEvent2Amt
Non Cash Prizes Event2	$22,224	NonCashPrizesEvent2Amt
Rent Facility Costs Event2	$300,930	RentFacilityCostsEvent2Amt
Food And Beverage Event2	$11,919	FoodAndBeverageEvent2Amt
Entertainment Event2	$426,882	EntertainmentEvent2Amt
Other Direct Expenses Event2	$181,809	OtherDirectExpensesEvent2Amt
Other Events Total	370	OtherEventsTotalCnt
Gross Receipts Other Events	$152,064,398	GrossReceiptsOtherEventsAmt
Charitable Contri Other Events	$122,883,839	CharitableContriOtherEventsAmt
Gross Revenue Other Events	$29,180,559	GrossRevenueOtherEventsAmt
Non Cash Prizes Other Events	$28,565	NonCashPrizesOtherEventsAmt
Rent Fclty Costs Other Events	$3,591,507	RentFcltyCostsOtherEventsAmt
Food And Beverage Other Events	$3,764,670	FoodAndBeverageOtherEventsAmt
Entertainment Other Events	$5,535,817	EntertainmentOtherEventsAmt
Oth Direct Expnss Other Events	$16,260,000	OthDirectExpnssOtherEventsAmt
Gross Receipts Total	$161,174,833	GrossReceiptsTotalAmt
Charitable Contributions Tot	$130,162,354	CharitableContributionsTotAmt
Gross Revenue Total Events	$31,012,479	GrossRevenueTotalEventsAmt
Non Cash Prizes Total Events	$50,789	NonCashPrizesTotalEventsAmt
Rent Fclty Costs Total Events	$3,932,425	RentFcltyCostsTotalEventsAmt
Food And Beverage Total Events	$4,119,354	FoodAndBeverageTotalEventsAmt
Entertainment Total Events	$6,337,143	EntertainmentTotalEventsAmt
Oth Direct Expnss Total Events	$16,572,768	OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events	$31,012,479	DirectExpenseSummaryEventsAmt

Gaming Information GamingInformationGrp

Field	Value	IRS element (for citing)
Gross Revenue Other Gaming	$1,471,255	GrossRevenueOtherGamingAmt
Cash Prizes Other Gaming	$59,238	CashPrizesOtherGamingAmt
Non Cash Prizes Other Gaming	$28,565	NonCashPrizesOtherGamingAmt
Volunteer Labor Other Gaming	false	VolunteerLaborOtherGamingInd
Gross Revenue Total Gaming	$1,471,255	GrossRevenueTotalGamingAmt
Cash Prizes Total Gaming	$59,238	CashPrizesTotalGamingAmt
Non Cash Prizes Total Gaming	$28,565	NonCashPrizesTotalGamingAmt
Direct Expense Summary Gaming	$87,803	DirectExpenseSummaryGamingAmt
Net Gaming Income Summary	$1,383,452	NetGamingIncomeSummaryAmt

Field	Value	IRS element (for citing)
States Where Gaming Conducted	AL	StatesWhereGamingConductedCd
States Where Gaming Conducted	AK	StatesWhereGamingConductedCd
States Where Gaming Conducted	AZ	StatesWhereGamingConductedCd
States Where Gaming Conducted	AR	StatesWhereGamingConductedCd
States Where Gaming Conducted	CA	StatesWhereGamingConductedCd
States Where Gaming Conducted	CO	StatesWhereGamingConductedCd
States Where Gaming Conducted	CT	StatesWhereGamingConductedCd
States Where Gaming Conducted	DE	StatesWhereGamingConductedCd
States Where Gaming Conducted	DC	StatesWhereGamingConductedCd
States Where Gaming Conducted	FL	StatesWhereGamingConductedCd
States Where Gaming Conducted	GA	StatesWhereGamingConductedCd
States Where Gaming Conducted	HI	StatesWhereGamingConductedCd
States Where Gaming Conducted	ID	StatesWhereGamingConductedCd
States Where Gaming Conducted	IL	StatesWhereGamingConductedCd
States Where Gaming Conducted	IN	StatesWhereGamingConductedCd
States Where Gaming Conducted	IA	StatesWhereGamingConductedCd
States Where Gaming Conducted	KS	StatesWhereGamingConductedCd
States Where Gaming Conducted	KY	StatesWhereGamingConductedCd
States Where Gaming Conducted	LA	StatesWhereGamingConductedCd
States Where Gaming Conducted	ME	StatesWhereGamingConductedCd
States Where Gaming Conducted	MD	StatesWhereGamingConductedCd
States Where Gaming Conducted	MA	StatesWhereGamingConductedCd
States Where Gaming Conducted	MI	StatesWhereGamingConductedCd
States Where Gaming Conducted	MN	StatesWhereGamingConductedCd
States Where Gaming Conducted	MS	StatesWhereGamingConductedCd
States Where Gaming Conducted	MO	StatesWhereGamingConductedCd
States Where Gaming Conducted	NE	StatesWhereGamingConductedCd
States Where Gaming Conducted	NV	StatesWhereGamingConductedCd
States Where Gaming Conducted	NH	StatesWhereGamingConductedCd
States Where Gaming Conducted	NJ	StatesWhereGamingConductedCd
States Where Gaming Conducted	NM	StatesWhereGamingConductedCd
States Where Gaming Conducted	NY	StatesWhereGamingConductedCd
States Where Gaming Conducted	NC	StatesWhereGamingConductedCd
States Where Gaming Conducted	ND	StatesWhereGamingConductedCd
States Where Gaming Conducted	OH	StatesWhereGamingConductedCd
States Where Gaming Conducted	OK	StatesWhereGamingConductedCd
States Where Gaming Conducted	OR	StatesWhereGamingConductedCd
States Where Gaming Conducted	PA	StatesWhereGamingConductedCd
States Where Gaming Conducted	RI	StatesWhereGamingConductedCd
States Where Gaming Conducted	SC	StatesWhereGamingConductedCd
States Where Gaming Conducted	SD	StatesWhereGamingConductedCd
States Where Gaming Conducted	TN	StatesWhereGamingConductedCd
States Where Gaming Conducted	TX	StatesWhereGamingConductedCd
States Where Gaming Conducted	UT	StatesWhereGamingConductedCd
States Where Gaming Conducted	VT	StatesWhereGamingConductedCd
States Where Gaming Conducted	VA	StatesWhereGamingConductedCd
States Where Gaming Conducted	WA	StatesWhereGamingConductedCd
States Where Gaming Conducted	WV	StatesWhereGamingConductedCd
States Where Gaming Conducted	WI	StatesWhereGamingConductedCd
States Where Gaming Conducted	WY	StatesWhereGamingConductedCd
Licensed	Yes (true)	LicensedInd
License Suspended Etc	false	LicenseSuspendedEtcInd
Gaming With Nonmembers	false	GamingWithNonmembersInd
Member Of Other Entity	false	MemberOfOtherEntityInd
Gaming Other Facility	1.00000	GamingOtherFacilityPct
Individual With Books	JIMMY CHAN	IndividualWithBooksNm

Persons With Books US Address PersonsWithBooksUSAddress

Field	Value	IRS element (for citing)
Address Line1	26 BROADWAY-14TH FLOOR	AddressLine1Txt
City	NEW YORK	CityNm
State Abbreviation	NY	StateAbbreviationCd
ZIP	10004	ZIPCd

Field	Value	IRS element (for citing)
Cntrct With3rd Prty For Game Rev	false	CntrctWith3rdPrtyForGameRevInd
Gaming Manager Person	JIMMY CHAN SR ACCCOUNTANT -JDRF	GamingManagerPersonNm
Gaming Manager Compensation	$0	GamingManagerCompensationAmt
Gaming Manager Services Prov	FILING GAMING APPLICATIONS AND REPORTS	GamingManagerServicesProvTxt
Gaming Manager Is Employee	Yes (X)	GamingManagerIsEmployeeInd
Charitable Distribution Rqr	false	CharitableDistributionRqrInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	SCHEDULE G, PART I, LINE 2	FormAndLineReferenceDesc
Explanation	INSURANCE AUTO AUCTIONS LLC IS A STATE LICENSED PROFESSIONAL FUNDRAISER THAT HANDLES ALL ASPECTS OF CARS BEING DONATED TO JDRF. DONORS CONTACT THE COMPANY DIRECTLY THROUGH A TOLL FREE NUMBER TO COORDINATE THE DONATION, FOLLOWING WHICH INSURANCE AUTO AUCTIONS HANDLES ALL REQUIRED IRS 1098C REPORTING. FOR THE PERIOD ENDING 6/30/19, THE CAR PROGRAM RAISED $261,400 WITH TOTAL EXPENSES OF $107,183 WITH THE NET PROCEEDS OF $154,217 PROVIDED DIRECTLY TO JDRF. JDRF PAYS NO ADDITIONAL EXPENSES OR FEES TO INSURANCE AUTO AUCTIONS FOR THIS PROGRAM.	ExplanationTxt

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (true)	GrantRecordsMaintainedInd

Recipient Table RecipientTable (87 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	Recipient EINRecipientEIN	IRC SectionIRCSectionDesc	Cash GrantCashGrantAmt	Valuation Method UsedValuationMethodUsedDesc	Non Cash AssistanceNonCashAssistanceDesc	Purpose Of GrantPurposeOfGrantTxt	Address Line2USAddress/AddressLine2Txt
BENAROYA RESEARCH INST AT VIRGINIA MASON
1201 9TH AVE	SEATTLE	WA	98101	910653422	501(C)3	$1,960,925	N/A	N/A
ANN AND ROBERT LURIE CHILDREN'S HOSPITAL
225 EAST CHICAGO AVENUE	CHICAGO	IL	60611	362170833	501(C)3	$60,000	N/A	N/A	IMMUNE THERAPIES
CAPILLARY BIOMEDICAL INC
56 HAVENWOOD	IRVINE	CA	92617	464787731		$590,000	N/A	N/A	IMMUNE THERAPIES
CORNELL UNIVERSITY
377 PINE TREE RD	ITHACA	NY	14850	150532082	501(C)3	$131,887	N/A	N/A	IMMUNE THERAPIES
CAM MED LLC
29 EXETER STREET	WEST NEWTON	MA	02465	999999999		$686,927	N/A	N/A	IMMUNE THERAPIES
UNIVERSITY OF ARIZONA
PO BOX 210158	TUCSON	AZ	85004	113661893	501(C)3	$599,963	N/A	N/A
CRITICAL PATH INSTITUTE
1730 EAST RIVER ROAD	TUCSON	AZ	85718	201991334	501(C)3	$228,000	N/A	N/A
INDIANA UNIVERSITY
980 INDIANA AVENUE	INDIANAPOLIS	IN	46202	356018940	501(C)3	$1,217,159	N/A	N/A
BETH ISRAEL MEDICAL CENTER
330 BROOKLINE AVE	BOSTON	MA	02215	135564934	501(C)3	$570,000	N/A	N/A
JOSLIN DIABETES CENTER
1 JOSLIN PL	BOSTON	MA	02215	042203836	501(C)3	$3,172,354	N/A	N/A
FREQUENCY THERAPEUTICS
300 TECHNOLOGY SQUARE	WOBURN	MA	01801	999999999		$122,415	N/A	N/A
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
77 MASSACHUSETTS AVE	CAMBRIDGE	MA	02139	042103594	501(C)3	$879,914	N/A	N/A
INDIANA BIOSCIENCES RES INST
1345 W 16TH STREET	INDIANAPOLIS	IN	46202	462882271	501(C)3	$150,000	N/A	N/A
MAYO CLINIC
1216 2ND ST SW	ROCHESTER	MN	55902	411405254	501(C)3	$186,794	N/A	N/A	IMMUNE THERAPIES
GEORGIA TECH RESEARCH CORP
505 TENTH STREET	ATLANTA	GA	30332	580603146	501(C)3	$358,716	N/A	N/A	IMMUNE THERAPIES
STANFORD UNIVERSITY
291 CAMPUS DRIVE	STANFORD	CA	94305	941156365	501(C)3	$962,302	N/A	N/A
HEALTH PARTNERS INSTITUTE
PO BOX 1524	MINNEAPOLIS	MN	55440	999999999		$261,319	N/A	N/A
RTI INTERNATIONAL
RES TRIANGLE PK	RES TRIANGLE	NC	27709	440680117	501(C)3	$66,700	N/A	N/A
OREGON HEALTH & SCIENCE UNIVERSITY
3181 SW SAM JACKSON	PORTLAND	OR	97239	237083114	501(C)3	$358,472	N/A	N/A	IMMUNE THERAPIES
IBM
1 N CASTLE DR	ARMONK	NY	10504	999999999		$1,465,000	N/A	N/A	IMMUNE THERAPIES
PACIFIC DIABETES TECHNOLOGIES
12154 SW GARDEN PLACE	PORTLAND	OR	97223	999999999	501(C)3	$147,126	N/A	N/A
UNIVERSITY OF FLORIDA
1600 SW ARCHER ROAD	GAINESVILLE	FL	32610	590974739	501(C)3	$1,659,166	N/A	N/A
UNIVERSITY OF VIRGINIA
104 MIDMONT LN	CHARLOTTESVILLE	VA	22902	416042488	501(C)3	$656,087	N/A	N/A
UNIVERSITY OF MICHIGAN
2003 S STATE STREET	ANN ARBOR	MI	48109	386006309	501(C)3	$1,129,564	N/A	N/A
LOCKHEED MARTIN
199 BORTON LANDING RD	MOORESTOWN	NJ	08057	999999999		$523,815	N/A	N/A	IMMUNE THERAPIES
UNIVERSITY OF CALIFORNIA
3333 CA ST	SAN FRANCISCO	CA	94122	956006143	501(C)3	$4,987,186	N/A	N/A
UNIVERSITY OF WISCONSIN-MADISON
1220 LINDEN DRIVE	MADISON	WI	53706	396006492	501(C)3	$499,527	N/A	N/A
UT SOUTHWESTERN MEDICAL CENTER
5323 HARRY HINES BLVD	DALLAS	TX	75390	756002868	501(C)3	$903,171	N/A	N/A
VANDERBILT UNIVERSITY MEDICAL CENTER
1211 MEDICAL CENTER DR	NASHVILLE	TN	37232	620476822	501(C)3	$866,610	N/A	N/A
LOUISIANA STATE UNIV HEALTH SCIENCE
433 BOLIVAR STREET	NEW ORLEANS	LA	70112	270158443	501(C)3	$125,000	N/A	N/A	IMMUNE THERAPIES
BAYLOR COLLEGE OF MEDICINE-RESEARCH INSTITUTE
ONE BAYLOR PLAZA	HOUSTON	TX	77030	751921898	501(C)3	$250,000	N/A	N/A
BROAD INSTITUTE
415 MAIN STREET	CAMBRIDGE	MA	02142	263428781	501(C)3	$250,000	N/A	N/A
NAT INST OF DIABETES & DIGESTIVE DISEASES
6707 DEMOCRACY BLVD	BETHESDA	MD	20892	999999999		$200,000	N/A	N/A
JAEB CENTER FOR HEALTH RESEARCH FND
15310 Amberly Drive	TAMPA	FL	33647	593187624	501(C)3	$2,718,325	N/A	N/A
YALE UNIVERSITY
PO BOX 209010	NEW HAVEN	CT	06520	060646973	501(C)3	$562,625	N/A	N/A	IMMUNE THERAPIES
SFC FLUIDICS INC
534 WEST RES CENTER	FAYETTEVILLE	AR	72701	999999999		$225,000	N/A	N/A	IMMUNE THERAPIES
UNIVERSITY OF ALABAMA AT BIRMINGHAM
1720 2ND AVS S	BIRMINGHAM	AL	35294	636001138	501(C)3	$303,695	N/A	N/A
MASSACHUSETTS GENERAL HOSPITAL
55 FRUIT STREET	BOSTON	MA	02114	042697983	501(C)3	$324,670	N/A	N/A
ICAHN SCHOOL OF MEDICINE MOUNT SINAI
1 GUSTAVE L LEVY PLACE	NEW YORK	NY	10029	136171197	501(C)3	$393,872	N/A	N/A
STATE UNIVERSITY OF NY AT BUFFALO
12 CAPEN HALL	BUFFALO	NY	14260	141368361	501(C)3	$840,067	N/A	N/A
ILLINOIS INSTITUTE OF TECHNOLOGY
3300 SOUTH FEDERAL STREET	CHICAGO	IL	60616	362170136	501(C)3	$220,484	N/A	N/A
UNIVERSITY OF MINNESOTA
200 OAK ST SE	MINNEAPOLIS	MN	55455	416007513	501(C)3	$3,798,470	N/A	N/A
JACKSON LABORATORY
600 MAIN STREET	BAR HARBOR	ME	04609	010211513	501(C)3	$314,398	N/A	N/A
RUTGERS THE STATE UNIVERSITY
175 UNIVERSITY AVE	NEWARK	NJ	07107	462354111	501(C)3	$243,892	N/A	N/A	IMMUNE THERAPIES
UNIVERSITY OF WASHINGTON
4333 BROOKLYN AVE NE	SEATTLE	WA	98195	911486484	501(C)3	$663,734	N/A	N/A
THE MEDICAL COLLEGE OF WISCONSIN
8701 W WATERTOWN	MILWAUKEE	WI	53226	611730890	501(C)3	$580,809	N/A	N/A	IMMUNE THERAPIES
THE BRIGHAM AND WOMEN'S HOSPITAL
75 FRANCIS STREET	BOSTON	MA	02115	042312909	501(C)3	$57,984	N/A	N/A	COMPLICATIONS
TIDEPOOL
555 BRYANT	ST PALO ALTO	CA	94301	462302287		$3,999,400	N/A	N/A	ARTIFICIAL PANCREAS
UNIVERSITY OF UTAH
201 PRESIDENTS CR	SALT LAKE CITY	UT	84112	876000525	501(C)3	$1,068,613	N/A	N/A	GLUCOSE MODULATION
PROTOMER TECHNOLOGIES
530 SOUTH LAKE AVE	PASADENA	CA	91101	474206994		$613,000	N/A	N/A	IMMUNE THERAPIES
UNIVERSITY OF SOUTHERN CALIFORNIA
3720 S FLOWER STREET	LOS ANGELES	CA	90089	951642394	501(C)3	$168,929	N/A	N/A	IMMUNE THERAPIES
UNIVERSITY OF COLORADO
1800 GRANT STREET	DENVER	CO	80203	846049811	501(C)3	$4,896,305	N/A	N/A	IMMUNE THERAPIES
UNIVERSITY OF ILLINOIS
1200 HARRISON	CHICAGO	IL	60612	376006007	501(C)3	$219,999	N/A	N/A	IMMUNE THERAPIES
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
1 COLLEGE HALL	PHILADELPHIA	PA	19104	231352685	501(C)3	$127,863	N/A	N/A	IMMUNE THERAPIES
UNITIO INC
11 AVENUE DE LAYFETTE	BOSTON	MA	02111	451623549		$1,000,000	N/A	N/A	IMMUNE THERAPIES
UNIVERSITY OF MARYLAND BALTIMORE
620 WEST LEXINGTON ST	BALTIMORE	MD	21201	522004514	501(C)3	$274,176	N/A	N/A	IMMUNE THERAPIES
UNIVERSITY OF TEXAS HEALTH SCIENCE
7703 FLOYD CURL DRIVE	SAN ANTONIO	TX	78229	741586031	501(C)3	$726,031	N/A	N/A	IMMUNE THERAPIES
WASHINGTON UNIVERSITY
One Brookings Drive	St Louis	MO	63130	430653611	501(C)3	$598,943	N/A	N/A	IMMUNE THERAPIES
VTV THERAPEUTICS LLC
4170 MENDENHALL OAKS	HIGH POINT	NC	27265	999999999		$1,829,999	N/A	N/A	IMMUNE THERAPIES
BOSTON CHILDREN'S HOSPITAL
300 LONGWOOD AVENUE	BOSTON	MA	02115	043266103	501(C)3	$1,704,794	N/A	N/A	IMMUNE THERAPIES
HARVARD COLLEGE
677 HUNTINGTON AVE	BOSTON	MA	02115	042103580	501(C)3	$471,632	N/A	N/A	IMMUNE THERAPIES
BAYLOR UNIVERSITY
1301 S UNIVERSITY PARKS DR	WACO	TX	76798	741159753	501(C)3	$109,478	N/A	N/A
CHILDREN'S RESEARCH INSTITUTE
801 ROEDER ROAD SUITE 500	SILVER SPRING	MD	20910	521654453	501(C)3	$60,000	N/A	N/A
DUKE UNIVERSITY
2138 CAMPUS DRIVE	DURHAM	NC	27708	560532129	501(C)3	$119,148	N/A	N/A		BOX 90586
IVIVA MEDICAL INC
100 CUMMINGS CENTER	BEVERLY	MA	01915	999999999		$30,000	N/A	N/A		SUITE 451C
JOHNS HOPKINS UNIVERSITY
3400 N CHARLES STREET	BALTIMORE	MD	21218	520595110	501(C)3	$150,000	N/A	N/A
NEW YORK MEDICAL COLLEGE
40 SUNSHINE COTTAGE RD	VALHALLA	NY	10595	131099420	501(C)3	$110,000	N/A	N/A
PACIFIC NORTHWEST RESEARCH INSTITUTE
720 BROADWAY	SEATTLE	WA	98122	910667886	501(C)3	$54,512	N/A	N/A
PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY
1 LETTERMAN DR STE D3500	SAN FRANCISCO	CA	94129	473355381	501(C)3	$1,105,190	N/A	N/A
PHYSIOLOGIC DEVICES INC
2232 OLD STAGECOACH TRAIL	ALPINE	CA	91901	999999999		$425,722	N/A	N/A
PUTNAM ASSOCIATES
501 BOYLSTON STREET	BOSTON	MA	02116	999999999		$279,000	N/A	N/A
QUAESTIO GLOBAL PARTNERS LLC
ONE KNOLLWOOD TERRACE	CHESTER	NJ	07930	999999999		$15,000	N/A	N/A
RENSSELAER POLYTECHNIC INSTITUTE
110 EIGHTH STREET	TROY	NY	12180	141340095	501(C)3	$200,000	N/A	N/A
SINCLAIR RESEARCH CENTER LLC
562 STATE ROAD DD	AUXVASSE	MO	65231	999999999		$139,776	N/A	N/A
STOWERS INSTITUTE FOR MEDICAL RESEARCH
1000 EAST 50TH STREET	KANSAS CITY	MO	64110	202993509	501(C)3	$149,993	N/A	N/A
THE OHIO STATE UNIVERSITY
281 W LANE AVE	COLUMBUS	OH	43210	261416129	501(C)3	$145,000	N/A	N/A
THE SCRIPPS RESEARCH INSTITUTE
10550 NORTH TORREY PINES ROAD	LA JOLLA	CA	92037	330435954	501(C)3	$880,000	N/A	N/A
UNIVERSITY OF CENTRAL FLORIDA
12201 RESEARCH PARKWAY	ORLANDO	FL	32826	592924021	501(C)3	$209,891	N/A	N/A		SUITE 501
THE UNIVERSITY OF IOWA
5-660 BOWEN SCIENCE BUILDING	IOWA CITY	IA	52242	426004813	501(C)3	$147,465	N/A	N/A		DEPARTMENT OF PHYSIOLOGY BIOPHYSI
THE UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER
1000 STANTON L YOUNG BLVD	OKLAHOMA CITY	OK	73104	731563627	501(C)3	$250,000	N/A	N/A
UNIVERSITY OF MIAMI
1320 S DIXIE HWY STE 760	CORAL GABLES	FL	33146	590624458	501(C)3	$1,288,377	N/A	N/A
UNIVERSITY OF NEBRASKA BOARD OF REGENTS
3835 HOLDREGE	LINCOLN	NE	68583	470049123	501(C)3	$249,998	N/A	N/A		VARNER HALL
VANDERBILT UNIVERSITY
2301 VANDERBILT PLACE	NASHVILLE	TN	37240	620476822	501(C)3	$260,816	N/A	N/A
VIRGINIA COMMONWEALTH UNIVERSITY
PO BOX 980568	RICHMOND	VA	23298	546001758	501(C)3	$110,000	N/A	N/A
WAKE FOREST UNIVERSITY HEALTH SCIENCES
1 MEDICAL CENTER BLVD	WINSTON SALEM	NC	27157	223849199	501(C)3	$110,000	N/A	N/A
WAVE 80 BIOSCIENCES
				999999999		$20,000	N/A	N/A
TETRAGENETICS INC
91 Mystic St	Arlington	MA	02474	999999999		$240,000	N/A	N/A	BETA CELL

Field	Value	IRS element (for citing)
Total501c3 Org	68	Total501c3OrgCnt
Total Other Org	19	TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	GRANT MONITORING PROCEDURES	FormAndLineReferenceDesc
Explanation	SCH-I PART I LINE 2 Research grants are awarded by JDRF's Research Committee comprised of "JDRF Board members and other volunteers" following the recommendations of an in-house team of professional scientific staff and with input from external scientific reviewers and patient advocates. The review process includes the following criteria: (1) The scientific merit of the proposed research outlined in a grant application and (2) The relationship of the proposed research to JDRF's goal to cure, prevent and treat T1D and its complications. The scientific research team and grant administration staff maintain close contact with grantees, providing advice,evaluation, research progress reports, helping disseminate research results and reviewing research expenditures versus agreed budgets.	ExplanationTxt

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
Housing Allowance Or Residence	Yes (X)	HousingAllowanceOrResidenceInd
Written Policy Ref T And E Expnss	Yes (true)	WrittenPolicyRefTAndEExpnssInd
Substantiation Required	false	SubstantiationRequiredInd
Compensation Committee	Yes (X)	CompensationCommitteeInd
Independent Consultant	Yes (X)	IndependentConsultantInd
Form990 Of Other Organizations	Yes (X)	Form990OfOtherOrganizationsInd
Compensation Survey	Yes (X)	CompensationSurveyInd
Board Or Committee Approval	Yes (X)	BoardOrCommitteeApprovalInd
Severance Payment	Yes (true)	SeverancePaymentInd
Supplemental Nonqual Rtr Plan	false	SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm	false	EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org	false	CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs	false	CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org	false	CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs	false	CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments	Yes (true)	AnyNonFixedPaymentsInd
Initial Contract Exception	false	InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (10 entries)

TitleTitleTxt	Base Compensation Filing OrgBaseCompensationFilingOrgAmt	Bonus Filing OrganizationBonusFilingOrganizationAmount	Other Compensation Filing OrgOtherCompensationFilingOrgAmt	Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt	Total Compensation Filing OrgTotalCompensationFilingOrgAmt
DEREK RAPP
PRESIDENT AND CEO	$550,000	$175,000	$75,000	$12,150	$36,939	$849,089
AARON KOWALSKI
CHIEF MISSION OFFICER	$410,667	$92,000	$0	$10,297	$38,419	$551,383
SANDRA HIJIKATA
CHIEF DEV OFFICER & ASST. SECY	$376,250	$67,500		$12,150	$9,044	$464,944
MARK GREENE THRU 518
FORMER CFO & ASST. TRES	$165,627		$186,250		$4,694	$356,571
JILL CLARK
CHIEF OF STAFF & ASST. SECY	$276,103	$77,500		$12,150	$7,101	$372,854
JONATHAN R BEHR
MANAGING DIRECTOR JDRF-T1D FND	$310,583	$188,750		$12,150	$39,504	$550,987
ALISA NORRIS
CHIEF MARKETING OFFICER	$360,000	$43,200		$12,150	$41,389	$456,739
JULIA GREENSTEIN
VP RESEARCH	$319,567			$12,150	$2,846	$334,563
SUSAN YUN
CHIEF PEOPLE OFFICER	$288,333	$65,000		$10,050	$8,597	$371,980
CYNTHIA RICE
SVP ADVOCACY AND POLICY	$277,405	$65,000		$12,150	$36,939	$391,494

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
HOUSING ALLOWANCE	SCHEDULE J PART I, LINE 1A Derek Rapp, Pres & CEO, received a housing allowance as per the terms of his employment agreement. For the 2018 calendar year, the housing allowance provided to Derek Rapp was $75,000; such amount was treated as taxable compensation and included in his Form W-2. This amount was also reported on Schedule J, Part II, Col. (B) (III).
NON-FIXED PAYMENTS	FORM 990, SCHEDULE J, PART I, LINE 7 JDRF AWARDS NON-FIXED PAYMENTS SUCH AS BONUSES ON A DISCRETIONARY BASIS TIED TO THE EMPLOYEES PERFORMANCE. THE NAMES OF EMPLOYEES AND THE AMOUNTS THAT WERE PAID ARE FOUND ON SCHEDULE J, PAGE 2, PART II, COL. (B) (II).
SEVERANCE PAYMENTS	SCHEDULE J, PART I, LINE 4A MARK GREENE RECEIVED A SEVERANCE PAYMENT OF $186,250 WHICH IS REPORTED ON SCHEDULE J, PART II, COL. (B)(III) OTHER REPORTABLE COMPENSATION.

Schedule M IRS990ScheduleM

Field	Value	IRS element (for citing)
Works Of Art		WorksOfArtGrp
Art Historical Treasures		ArtHistoricalTreasuresGrp
Art Fractional Interest		ArtFractionalInterestGrp
Books And Publications		BooksAndPublicationsGrp
Clothing And Household Goods		ClothingAndHouseholdGoodsGrp

Cars And Other Vehicles CarsAndOtherVehiclesGrp

Field	Value	IRS element (for citing)
Non Cash Checkbox	Yes (X)	NonCashCheckboxInd
Contribution	2	ContributionCnt
Noncash Contributions Rpt F990	$28,566	NoncashContributionsRptF990Amt
Method Of Determining Revenues	TICKET SALES	MethodOfDeterminingRevenuesTxt

Field	Value	IRS element (for citing)
Boats And Planes		BoatsAndPlanesGrp
Intellectual Property		IntellectualPropertyGrp

Securities Publicly Traded SecuritiesPubliclyTradedGrp

Field	Value	IRS element (for citing)
Non Cash Checkbox	Yes (X)	NonCashCheckboxInd
Contribution	508	ContributionCnt
Noncash Contributions Rpt F990	$8,431,951	NoncashContributionsRptF990Amt
Method Of Determining Revenues	NET PROCEEDS OF SALE	MethodOfDeterminingRevenuesTxt

Field	Value	IRS element (for citing)
Securities Closely Held Stock		SecuritiesCloselyHeldStockGrp
Secur Prtnrshp Trust Intrsts		SecurPrtnrshpTrustIntrstsGrp
Securities Miscellaneous		SecuritiesMiscellaneousGrp
Qualified Contrib Hist Struct		QualifiedContribHistStructGrp
Qualified Contrib Other		QualifiedContribOtherGrp
Real Estate Residential		RealEstateResidentialGrp
Real Estate Commercial		RealEstateCommercialGrp
Real Estate Other		RealEstateOtherGrp
Collectibles		CollectiblesGrp
Food Inventory		FoodInventoryGrp
Drugs And Medical Supplies		DrugsAndMedicalSuppliesGrp
Taxidermy		TaxidermyGrp
Historical Artifacts		HistoricalArtifactsGrp
Scientific Specimens		ScientificSpecimensGrp
Archaeological Artifacts		ArchaeologicalArtifactsGrp

Other Non Cash Contri Table OtherNonCashContriTableGrp

Field	Value	IRS element (for citing)
Non Cash Checkbox	Yes (X)	NonCashCheckboxInd
Desc	MISC AUCTION ITEMS DONATED	Desc
Contribution	28000	ContributionCnt
Noncash Contributions Rpt F990	$12,839,321	NoncashContributionsRptF990Amt
Method Of Determining Revenues	FAIR MARKET VALUE	MethodOfDeterminingRevenuesTxt

Field	Value	IRS element (for citing)
Form8283 Received	0	Form8283ReceivedCnt
Any Property That Must Be Held	false	AnyPropertyThatMustBeHeldInd
Review Process Unusual NC Gifts	Yes (true)	ReviewProcessUnusualNCGiftsInd
Third Parties Used	Yes (true)	ThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDesc

ExplanationExplanationTxt

THIRD PARTY ASSISTANCE

LINE 32B INSURANCE AUTO AUCTIONS LLC IS A THIRD PARTY CAR DONATION COMPANY THAT HANDLES ALL ASPECTS OF CARS BEING DONATED TO JDRF. DONORS CALL A TOLL FREE NUMBER AND THEY ARE PUT IN CONTACT WITH A TOWING SERVICE IN THEIR AREA. AFTER THE CAR IS DONATED, INSURANCE AUTO AUCTIONS HANDLES ALL IRS 1098-C REPORTING. INSURANCE AUTO AUCTIONS IS A LICENSED PROFESSIONAL FUNDRAISER AND IS LICENSED IN THE STATES THAT REQUIRE IT TO REGISTER. FOR THE PERIOD ENDING 6/30/19, INSURANCE AUTO AUCTIONS LLC RAISED $261,400 WITH TOTAL EXPENSES OF $107,183. A NET CHECK IS PAID DIRECTLY TO JDRF. JDRF DOES NOT PAY INSURANCE AUTO AUCTIONS ANY EXPENSES OR FEES DIRECTLY. TOTAL NET REVENUE FOR FY-19 WAS $154,217.

NONCASH CONTRIBUTIONS

FORM 990, SCHEDULE M, PAGE 1 TYPES OF PROPERTY AND THE AMOUNTS LISTED IN PART I LINES 6, 9, and 25 ARE THE ACTUAL AMOUNT THAT DONORS HAVE DONATED FOR VEHICLES, SECURITIES, AND MISC ITEMS THAT ARE SOLD AT VARIOUS AUCTIONS & RAFFLES.

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (7 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
NET UNRELATED BUSINESS TAXABLE INCOME	FORM 990, PART I, LINE 7B INCLUDES 512(A)(7) AMOUNTS THAT ARE NOT REVENUE AND, THEREFORE, NOT REPORTED AS SUCH ON FORM 990.
PUBLIC DOCUMENTS	FORM 990, PAGE 6, PART VI, SECTION C, LINE 19 The organization makes its governing documents, conflict of interest policy and financial statements available to the public on its website: www.JDRF.org. The public may access copies of JDRF's W-9, annual reports, 990 tax returns, 501(c)(3) IRS letter, and audited financials, at the following link: www.jdrf.org/about/financials
EXECUTIVE COMPENSATION POLICY	PART VI, SECTION B, LINES 15a & 15b JDRF's Board of Directors charges a Talent and Compensation Committee to develop and recommend a compensation philosophy that applies to all employees of JDRF, including recommendations regarding the compensation and benefits of JDRF senior management for approval by the Board of Directors. The Committee works in collaboration with the President and CEO and the Chief People Officer and other senior staff personnel in the JDRF Human Resources Department to ensure that 1) the Foundation's talent strategy supports and is aligned with its overall organization strategies; 2) JDRF is in compliance with IRS guidelines for determining reasonableness in pay practices; and 3) overall compensation for JDRF's key executives is competitive and aligned with pay philosophy. To attract and retain top scientific and executive talent to advance its mission, the organization pays competitive and appropriate salaries as determined by analysis of reliable data and input from independent third-party consultants. The review of JDRF executive compensation and benefits under the procedures noted above is completed annually by an independent Compensation Committee, and the basis for their determination is documented contemporaneously in the minutes of the Committee's meetings, including most recently on June 20, 2019.
FORM 990 REVIEW PROCESS	SECTION B, PART VI, QUESTION 11B JDRF has a rigorous standard approach to reviewing its 990. The Organization's Accounting Manager works with its outside tax professionals to prepare the return and all supporting schedules. The draft return is reviewed by a number of individuals, including JDRF's Chief Financial Officer and AVP, FINANCE and Finance, the Chief Executive Officer, other executives, its external senior tax advisor and others as necessary to ensure accuracy. Any questions and changes with respect to the draft return are addressed. Following this process, the return is reviewed by JDRF's Audit Committee of the Board of Directors with its outside tax advisors. Once approved, the return is distributed to all members of JDRF's Board of Directors for review and comment before it is filed with the Internal Revenue Service.
PART III: STATEMENT OF PROGRAM SERVICE ACCOMPLISHMENTS	LINE 4A ($89,137,491) RESEARCH GRANTS JDRF has played a significant role in nearly every T1D therapeutic advance made in the last 50 years. Our funding supports more than 500 active T1D research grants in the United States and 21 other countries around the world including more than 150 grants in 2019 alone, plus 75 clinical trials. We leverage partnerships with academia, industry and clinicians to accelerate the most promising research opportunities. Our highest priority is developing cures for T1D and improving lives of those living with the disease today, including research in glucose control and prevention of T1D complications. The full impact of JDRF's research investment extends well beyond direct funding. Through advocacy and influence, JDRF drives funding from other sources into the T1D research and has helped secure passage of the Special Diabetes Program, putting more than $2.8 billion in federal funding toward T1D research over the last two decades. In addition, JDRF founded the JDRF T1D Fund (www.t1dfund.org). The wholly owned subsidiary of JDRF, the Fund is a venture philanthropy fund accelerating life-changing solutions to treat, prevent and cure T1D through catalytic commercial investments. Through its investments in partnership with private capital, including venture capital, pharma and foundations, the T1D Fund seeks to attract the private investment necessary to advance drugs, devices, diagnostics, and vaccines to help people living with T1D or at risk of developing the disease. The T1D Fund invests in opportunities that drive our mission, with an exclusive focus on the best commercial opportunities. All funds go directly to support companies developing approaches to treat, prevent and cure T1D. In accordance with GAAP, $21.4MM of the T1D Fund's total investments as of June 30, 2019 are reflected in the Balance Sheet (Part X) and not included within the organization's research-related mission expense. The foundation's diversified research portfolio includes a focus on Curing T1D and Improving Lives. Curing T1D We face two key challenges in Curing T1D. We must prevent, stop or reverse: the loss of insulin-producing beta cells, and the immune systems attack on beta cells. JDRF is accelerating our work in Curing T1D by focusing on the two areas that have advanced dramatically over the last years: Beta Cell Therapies and Immune Therapies. Beta Cell Therapies: focus on replacing insulin-producing beta cells from outside sources and on internally regenerating and protecting existing beta cells. Through donor-funded research, we now know that when someone has T1D, their own body turns on itself, attacking and destroying the beta cells that create insulin. Understanding the role of beta cells -- was a breakthrough. If we can save beta cells, we can help cure T1D. Immune Therapies: focus on ways to keep the immune system from attacking and destroying beta cells, and to prevent the onset and advancement of T1D. Research has shown that immune therapies can interact with a persons immune system, training it to combat internal battles like cancer or autoimmune diseases like rheumatoid arthritis and T1D. While T1D remains one of the only major autoimmune diseases without an effective drug therapy, we know we are getting close. Improving Lives T1D brings with it daily struggles and stress that that make the challenges of living a healthy and long life with T1D very real. JDRF fights every day to advance research and technology that can reduce the burden of living with T1D and keep people as healthy as possible until we find cures. Specifically, we are striving to improve lives by driving research and work in Glucose Control Therapies and Complications Therapies which includes psychosocial well-being. Glucose Control Therapies: focus on helping those with T1D manage glucose levels and overall metabolic balance, including improved artificial pancreas technology, developing next-generation insulins and developing new drugs that control glucose in novel ways. We know that less than 30% of people with T1D in the U.S. consistently maintain target blood-glucose control levels meaning that 70% are at risk of serious health issues. Aiming to ensure our community is healthy when cures are found, we will continue our focus on bringing new innovation to this area, including improved artificial pancreas technology, next-generation insulins and new drugs that control glucose in novel ways. Complications Therapies: focus on accelerating therapies to prevent and treat kidney and eye disease and improving psychosocial well-being. We know that more than 90% of people with T1D develop eye disease within 20 years of diagnosis and that 1 in 4 develop kidney disease. We also know that prevalence of suicide is higher among young adults with T1D. Our focus on complications will be on accelerating therapies that prevent and treat kidney and eye disease. We also are expanding our support of psychosocial wellbeing. We have been supporting research of psychosocial wellbeing for several years. Now we are increasing our support as early research has shown that the burden of living with T1D takes a toll well beyond physical complications. Research also has shown us that young adults and teens with T1D are often impacted the most, with a significantly higher suicide rate. This is alarming and is our call to step up this work to help make a positive difference. LINE 4B ($16,986,262) RESEARCH SUPPORT JDRF's in-house team of skilled and credentialed scientific, policy and government relations professionals play critical roles in leading and supporting the research strategy and distribution of research funds from JDRF - and our partner organizations toward creating a world without T1D. Our professionals identify, evaluate and influence groundbreaking research for funding and work with other foundations, governments and industry to accelerate the mission we all share. JDRF professionals work with regulatory and policy officials to ensure research can proceed without delay and that advances are well understood by healthcare decision makers. As part of these efforts, JDRF organizes and funds scientific meetings, symposia, and conferences to review research proposals, ensure that JDRF's research strategy is aligned with the needs of the T1D community, and allow JDRF to provide scientific updates on the research it manages. This effort ensures that all the research is continually shared and built upon by T1D researchers around the globe. JDRF's external Research Advisory Committee (RAC) is composed of professionals who are internationally renowned for their expertise in research as well as the care and treatment of people with T1D. The RAC advises on policies related to research philosophy and procedures. JDRF's work to bring together the best minds in the field enhances JDRF's ability to forecast future scientific direction, judge the potential effectiveness of new pathways, and identify gaps where JDRF funding can make the most impact. LINE 4C ($53,426,056) PUBLIC EDUCATION JDRF is uniquely qualified to provide public education about diabetes and its complications. JDRF's efforts impact not only the millions of people living with T1D, their families and the general public, but also those at risk for developing the disease. T1D strikes both children and adults suddenly, and the critical adjustment period following a diagnosis can be overwhelming. That's why we support families navigating this challenging time. JDRF also educates people about the warning signs of T1D, aimed at ensuring timely diagnoses and reducing the potential catastrophic consequences of undiagnosed T1D. JDRF also provides information and updates about current research directions and progress and about human clinical trials that are seeking participants (including through JDRF's Clinical Trials Connection matching tool: www.jdrf.org/research/clinical-trials). Through all of our national U.S. chapters; five international affiliates in Australia, Canada, Israel, the Netherlands and United Kingdom; the 30,000 members of our social network, TypeOneNation; and more than one million supports, JDRF fights to meet T1D community's diverse needs, connecting people with local support, expert resources, and the global effort to create a world without T1D.
CONFLICT OF INTEREST POLICY	FORM 990- PART VI-SECT B, LINE 12C All officers, directors, key employees, board and committee members (both chapters and international boards) are required to sign a conflict of interest policy annually and disclose any conflicts. The Office of the President and CEO manages this process, and JDRF's internal audit department annually audits to ensure compliance. If any conflict does arise, the board members with the conflicts will recuse themselves from the meeting and/or vote.
NET ASSET CLASSIFICATION	FORM 990, PART X, LINES 27-29: THE FASB ISSUED ACCOUNTING STANDARDS UPDATE (ASU) 2016-14 NOT-FOR-PROFIT ENTITIES (TOPIC 958), PRESENTATION OF FINANCIAL STATEMENTS OF NOT-FOR-PROFIT ENTITIES, WHICH AMONG OTHER THINGS, CHANGES HOW NOT-FOR-PROFIT ENTITIES REPORT NET ASSET CLASSES. THE SIGNIFICANT REQUIREMENTS OF ASU 2016-14 INCLUDE REDUCTION IN THE NUMBER OF NET ASSET CLASSES FROM THREE TO TWO: WITH DONOR RESTRICTIONS (FORMERLY REPORTED AS TEMPORARILY RESTRICTED NET ASSETS) AND WITHOUT DONOR RESTRICTIONS (FORMERLY REPORTED AS UNRESTRICTED NET ASSETS). THE 2018 FORM 990, PART X WAS NOT UPDATED TO REFLECT THE CHANGES IN NET ASSET CLASS TERMINOLOGY; THEREFORE, JDRF HAS REPORTED NET ASSETS WITHOUT DONOR RESTRICTION AS UNRESTRICTED NET ASSETS AND NET ASSETS WITH DONOR RESTRICTION AS TEMPORARILY RESTRICTED NET ASSETS AND PERMANENTLY RESTRICTED NET ASSETS, AS APPLICABLE.

Schedule R IRS990ScheduleR

Id Disregarded Entities IdDisregardedEntitiesGrp

Disregarded Entity Name DisregardedEntityName

Field	Value	IRS element (for citing)
Business Name Line1	JDRF T1D FUND LLC	BusinessNameLine1Txt

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	C/O JDRF - 26 BROADWAY 14TH FLOOR	AddressLine1Txt
City	NEW YORK	CityNm
State Abbreviation	NY	StateAbbreviationCd
ZIP	10004	ZIPCd

Field	Value	IRS element (for citing)
EIN	274967989	EIN
Primary Activities	FUNDR/INVEST	PrimaryActivitiesTxt
Legal Domicile State	DE	LegalDomicileStateCd
Total Income	$14,902,601	TotalIncomeAmt
End Of Year Assets	$71,893,780	EndOfYearAssetsAmt

Direct Controlling Entity Name DirectControllingEntityName

Field	Value	IRS element (for citing)
Business Name Line1	JDRF	BusinessNameLine1Txt

Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp

Related Organization Name RelatedOrganizationName

Field	Value	IRS element (for citing)
Business Name Line1	CHARITABLE REMAINDER TRUST (5)	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Primary Activities	ANNUITY	PrimaryActivitiesTxt
Legal Domicile State	PA	LegalDomicileStateCd
Controlled Organization	Yes (true)	ControlledOrganizationInd

Field	Value	IRS element (for citing)
Receipt Of Int Annts Rnts Rylts	false	ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org	false	GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org	false	GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org	false	LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org	false	LoansOrGuaranteesFromOthOrgInd
Asset Sale To Other Org	false	AssetSaleToOtherOrgInd
Asset Purchase From Other Org	false	AssetPurchaseFromOtherOrgInd
Asset Exchange	false	AssetExchangeInd
Rental Of Facilities To Oth Org	false	RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org	false	RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org	false	PerformOfServicesForOthOrgInd
Perform Of Services By Other Org	false	PerformOfServicesByOtherOrgInd
Sharing Of Facilities	false	SharingOfFacilitiesInd
Paid Employees Sharing	false	PaidEmployeesSharingInd
Reimbursement Paid To Other Org	false	ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org	false	ReimbursementPaidByOtherOrgInd
Transfer To Other Org	false	TransferToOtherOrgInd
Transfer From Other Org	false	TransferFromOtherOrgInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	SCHEDULE R, PART I, LINE (1B)	FormAndLineReferenceDesc
Explanation	THE PRIMARY ACTIVITY FOR THE JDRF T1D FUND IS FUNDRAISING AND INVESTING IN TYPE ONE DIABETES RESEARCH. PLEASE SEE DETAILED DESCRIPTION ON SCHEDULE O, PART III, LINE 4A, STATEMENT OF PROGRAM SERVICE ACCOMPLISHMENTS FOR RESEARCH GRANTS.	ExplanationTxt